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ABSTRACT
Non-alcoholic fatty liver disease (NAFLD) is an emerging worldwide pandemic
which is highly prevalent among obese individuals including children and adults. In a
NAFLD condition, exposure to environmental contaminants or toxins can act as a second
/ multiple hit, which leads to the progression of simple steatosis to NASH and ultimately
may result in liver cirrhosis. With climate change today, elevated levels of microcystins
are an emerging problem in fresh water bodies, which are a source of drinking water.
Individuals are therefore at risk of exposure to microcystin through consuming
contaminated water. In the progression of NAFLD from one clinical stage to
another, microcystin can play an important role. Research has proved that the main
mechanism of the Microcystin-LR is to work as an exogenous Protein phosphatase 2A
(PP2A) inhibitor. In this thesis we test the hypothesis that microcystin activates Kupffer
cells as well as the hepatic stellate cells, which are the crucial mediators in hepatic
inflammation and fibrogenesis via NOX2 dependent pathway in NAFLD condition.
Results showed that microcystin exposure via intraperitoneal routes in mice that have mild
steatosis will lead to advanced histopathological characteristics of NAFLD. Further, we
looked at the effect of early microcystin exposure in young mice, which were then fed a
high fat diet to induce obesity/NAFLD. Early exposure to microcystin resulted in
exacerbation of NAFLD clinical pathology with increased expression of proinflammatory
cytokines, compared to vehicle control treated mice. This process has been shown to be
reduced in mice that lacked miR21, p47 phox , or NLRP3 genes. In addition, inhibition of
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AKT pathway reduced microcystin -induced NOX2 activation as well as upregulation of
miR21. All things considered, it was observed that microcystin exposure exacerbated
NAFLD pathology via activating NOX2-dpendent peroxynitare generation by increasing
miR21 levels. Moreover, early childhood exposure to microcystin will exacerbate adult
hepatic injury following HFD via NLRP3 inflammasomes.
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CHAPTER 1
INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is a pathological condition mostly
similar to histological features of alcoholic liver disease , but occurs without excessive
consumption of alcohol [1, 2]. It includes a wide spectrum of liver stages based on
different histological features ranging from simple steatosis to a complex stage of
nonalcoholic steatohepatitis (NASH), which may progress to hepatic cirrhosis and
hepatocellular carcinoma if it remains untreated. The main issue of the first two liver
stages is that most patients are completely fine and asymptomatic at the beginning until
they reach irreversible end-stage liver disease [3-5]. This silent liver disease has recently
become an imperative public health concern because of its high prevalence among both
adults as well as in juveniles, its high risk of progression to advanced severe liver illnesses
if neglected, and its strong association with an environmental contaminant [6, 7]. Our group
as well as other research studies have shown that environmental exposure to contaminants
as well as toxicants and/or potentially their metabolites work as a “second and/or multiple
hit” in order to exacerbate the pathophysiology of NAFLD [6, 8]. The ‘first hit’ includes
metabolic changes in body system that involve leptin resistance and/or insulin resistance,
which in turn result in fat accumulation in the liver (liver steatosis). The first hit can be
synergized if obesity was there as it causes increase in the level of leptin. The ‘second hit’
generally involves pathological state of imbalance that includes a condition such as
oxidative stress resulting in Kupffer cells activation, as well as Stellate cells activation.
1

These cells activation subsequently result in proinflammatory response and fibrogenesis
[9-12].
Nonalcoholic fatty liver disease (NAFLD) is a clinical condition that is related to
the rising levels of obesity and metabolic disorders [13].NAFLD are most predominant in
adult obese individuals with high prevalence among them which is around 80-90%.
Patients with metabolic disorders such as diabetes mellitus have prevalence of 30-50%.
This percentage will get increased up to 90% if it is synergized with a condition like
hyperlipidemia. In pediatrics epidemiology, a NAFLD condition is challenging as that
children have prevalence of 3-10%. However, this percentage can get a dramatic increase
to reach 70 % among obese children [14].
Obesity is a condition that is associated with different factors that promote a liver
steatosis stage. For example, liver steatosis happens because of exaggerated consumption
of a high fat diet and the other metabolic factors and syndromes such as NAFLD that is
associated with decreased fat export in very low density lipoprotein( VLDL), increased de
novo lipogenesis process, as well as decreased free fatty acid β-oxidation [10]. We can
consider obesity as a pathological condition because it is associated with
elevated concentrations of pro inflammatory factors such as cytokines,

like Tumor

necrosis factor (TNF-α), Interleukin 1β (IL-1β) ,Interleukin 6 (IL-6), and Monocyte
chemoattractant protein 1 (MCP1) [15]. Moreover, hormones such as adipokines can work
as proinflammatory factors in obese individuals. For example, leptin can behave as a
cytokine in the body system [16]. This hormone is regularly secreted in a pulsatile
phenomenon by the adipocytes and works physiologically as the satiety hormone [16, 17].
It has been already shown by our group that mice groups that were fed with a high fat diet
2

and had been exposed to BDCM had increased leptin concentration [6, 18]. Moreover, mice
that had leptin KO gene associated with leptin deficiency showed signs of hyperphagia
and mice became extremely obese as leptin is required after eating to control hunger. Also,
this hormone is known to be positively associated with the body fat content. This is because
the hormone specifically works to regulate and change long-term food intake as well as
affecting energy expenditure in whole body systems [19].
Data from the Centers for Disease Control indicate that over a third of the entire
country’s population is obese. Overall, a significant portion of the adult population in the
nation is affected by obesity, which is a primary risk factor in the development of many
diseases. According to Ogden et al,it is estimated that 38.3 percent and 34.3 percent of
women and men respectively are affected by obesity in the country [20] . Obesity as an
issue tends to follow precepts of age where it progresses in severity. However, for
particular races, Blacks and Hispanics, obesity is far more prevalent in youth. For instance,
prevalence of obesity among participants from these races who are between 2 and 20 years
of age was at about 17 percent. This is a considerable figure given the age in life and lower
prevalence of risk factors, further indicating the gravity of the situation. With these
statistics according to Centers for Disease Control and Prevention (CDC, 2010), 12.7
million children and adolescents are affected. Obesity is the second leading cause of
preventable death in the United States after tobacco with an average toll of 300,000
annually.
Hepatocyte is one of the major elements of the liver parenchyma with multiple liver
functions; one of its the important functions is to play a role in controlling carbohydrate
metabolism by maintaining glucose concentrations in a normal range [21], Lipid
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metabolism and its modulation are also controlled by the hepatocytes [22], etc. On the other
hand, Kupffer cell, which is a specialized macrophage that resides in the liver, that liver, is
situated inside the hepatic sinusoids as it shown by many researchers. It is plays a key role
in the innate immunity of the liver and is also involved in different stress situations such
as infection, toxins, ischemia, resection and other stresses [23] . They are representing
approximately 80-90% of all tissue macrophages in the body. Stellate cells which is also
known as Ito cells ,cells, are responsible for liver fibrosis as a response to different stressors
[24, 25]. All above cells has shown role in advancing NAFLD progression into NASH [6,
12, 26]. For example according to Lanthier, Kupffer cells activation is considered as key
element disease initiation and progression from NAFLD to NASH, while stellate cells are
known to contribute to fibrosis as well as hepatocytes ballooning were found to be crucial
in progression of NAFLD to NASH [27, 28].
Regarding how these environmental contaminants cause oxidative stress remains
unclear. We and others have previously shown that the environmental toxin such as
trihalomethane, pyrazole exacerbates NAFLD via oxidative stress induced by free radical
mechanism, thus suggesting that reactive oxidative species and reactive nitrosative species
play a critical role in the pathogenesis of environmental toxin induced NASH [6, 25, 29] .
Previous studies have shown that the potential sources of oxidative stress includes xanthine
oxidase (XDH) [30], electron transport chain enzymes, liver cytochrome P450-2E1
(CYP2E1) [31], and catalytic subunit of nicotinamide adenine dinucleotide phosphateoxidase (NADPH oxidase or NOX) [32]. NADPH oxidase is a membrane bound
oxidoreductase enzyme complex with a membranous subunit and cytoplasmic subunit. The
dormant NOX complex is activated to assemble in the membrane and produce superoxide
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radicals in a respiratory burst or environmental toxin [33]. Both the expression and activity
of the NOX2 (NOX isoforms) is increased in the NAFLD liver and, importantly, increased
expression correlates well with NAFLD severity [34].
The proliferation and expansion of harmful algal blooms (HABs) or toxic
cyanobacterial blooms are an important consequence of climate change [35]. These HAB
contain cyanobacteria which produce toxic metabolites and these often end up in drinking
water for humans and livestock [36]. According to WHO guidelines, the amount of MCLR in drinking water should not exceed1µg/L [37]. However, MC-LR was found to occur
in very high concentrations in several water bodies, which are a source of drinking water
to both livestock and human [38]. For instance, Poyang Lake (largest fresh water lake in
China) and Hoan Kiem Lake of northern Vietnam recorded 7.97 µg/L and 46 µg/L
respectively [38]. There are different routes for exposure to the microcystin; drinking water
is considered the most common route. There are other routes such as ingestion of
contaminated food, by inhalation and dermal contact during bathing or showering, and
during recreational activities [39, 40]. Inhalation exposure also has been reported as
another route for microcystin exposure [41].
Among other cyanotoxins (saxitoxin, anatoxin, cylindrospermopsin), microcystin
have been the most studied cyanotoxin so far [37]. Microcystin-LR is known to be a potent
toxin that can cause damage to different organs and body systems [42]. The liver is
considered to be an important target because of its toxicity and because it is known to be a
potent hepatotoxin. Regarding its chemistry, it has a heptapeptide structure and has a
molecular weight that varies between 900 and 1,100 Daltons. Based on the changes on
amino acid position, it will have different Congener within X and Y direction. Microcystin5

LR, which has leucine (L) and arginine (R) in the X and Y, is considered the most important
one because it’s potent toxicity and most encountered variant Congener with different
exposure routes among the microcystin family [43].
More than one species of cyanobacteria can synthesize the cyanotoxin [43].
Microcystin is an example of cyanotoxins produced by cyanobacteria Microcystis
aeruginosa in HAB [44]. Microcystin as well as other toxins remain preserved inside the
cyanobacteria cell structure until unusual conditions happen that favor cell wall lysis. So,
the cyanotoxin gets out of the cyanobacteria, called blue-green algae, contaminating the
fresh water as it is predominant in eutrophic (nutrient-rich) water bodies [45].
(WHO) set a guideline for MC-LR in drinking water which is 1µg/L [37]. However,
MC-LR was found to be more than the recommended guideline in many water bodies [38].
For instance, Poyang Lake (largest fresh water lake in China) and Hoan Kiem Lake of
northern Vietnam recorded 7.97 µg/L and 46 µg/L respectively [38].
MC-LR is chemically stable, resistant to gastro-intestinal digestion and transported
to the liver via active transport system. In addition, it shows toxic effects to liver cells.
Microcystin needs a facilitated transport system in order to get inside the cell using
receptors which is the organic acid transporter polypeptide (OATp) family [46-48]. This is
because microcystin has molecular weight that is very high, preventing it from passing to
the cells via simple diffusion [49].
Microcystin-LR down regulates with serine/ threonine protein phosphatases
(protein phosphatases) such as Protein phosphatase 2A (PP2A) after cell being exposed to
microcystin [50]. Most of the mechanistic actions regarding microcystin effect have been
6

shown by hyperphosphorylation of the proteins by decreased dephosphorylation process
by a phosphatase enzyme as it is known to be a potent inhibitor of PP2A [51].
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) has
different isoforms such as NOX1-5 and Doux1-2. NOX2, which is one of the isoforms and
can be considered as an important cellular source for reactive oxygen species(ROS) [52].
NOX2 has been proven to be expressed in the hepatocyte as well as has been proven in
several studies that its expression in different cell types such as smooth muscle cells,
Kupffer cells and hepatic stellate cells [53-55]. NOX2, in order to be activated, has six
different subunits and it needs two subunits of the six, (α subunit, and β subunit) depending
on tissue or cell type, to interact together in order to form an active enzyme complex [55].
Then, when it is activated, it will result in generating superoxide anion and reactive oxygen
species (ROS) [56]. For example, during activation of Kupffer cells, P47 Phox subunit will
be translocated to the cell membranes to bind GP91 Phox subunit. We have shown this
activation via translocation by showing significant increase in the protein colocalization
events by using dual staining using immunofluorescence microscopy [55, 57].
MicroRNAs (miRs) are very small noncoding RNAs that control both mRNA and
target gene protein expression, leading to changes in mRNA stability or inhibition of
translation depending on MicroRNA itself. For example, MicroRNAs are about 22
nucleotides, that is the reason for considering them small noncoding RNAs . One aspect
related to them is that miRNAs form mRNA silencing complexes in cytoplasm that can
regulate as well as control mRNA expression at transcription stage [58]. Downregulation
or upregulation of miRNAs can determine the pathway of the cellular mechanism. For
example, activation of leptin-mediated NADPH oxidase was positively associated with
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higher levels of miR21 expression in NASH condition. MicroRNA 21 among all miRNAs,
has been discovered as an important player in NASH pathophysiology [59, 60].
In this dissertation, I inspect cues in mechanism pathways of microcystin exposure
in liver in Non-alcoholic fatty liver disease (NAFLD) causing Nonalcoholic steatohepatitis
(NASH) and liver injury. One of these mechanisms is that microcystins can exacerbates
NAFLD pathophysiology via generation of peroxynitrite that is NOX2-dependent , via
increasing pathology caused by miR21. Moreover, early exposure to microcystins
following diet induced obesity will result in liver injury via activation of inflammasome.
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CHAPTER 2
EXOGENOUS PP2A INHIBITOR EXACERBATES THE
PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE VIA
NOX2-DEPENDENT ACTIVATION OF MIR211

1

Albadrani M, Seth RK, Sarkar S, Kimono D, Mondal A, Bose D, Porter DE, Scott GI, Brooks B,
Raychoudhury S, Nagarkatti M, Nagarkatti P, Jule Y, Diehl AM, Chatterjee S. Exogenous PP2A inhibitor
exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.
Am J Physiol Gastrointest Liver Physiol 317: G408 –G428, 2019.
Reprinted here with the permission of the publisher.
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Abstract:
Nonalcoholic fatty liver disease (NAFLD) is an emerging global pandemic. Though
significant progress has been made in unraveling the pathophysiology of the disease, the
role of protein phosphatase 2A (PP2A) and its subsequent inhibition by environmental and
genetic factors in NAFLD pathophysiology remains unclear. The present report tests the
hypothesis that an exogenous PP2A inhibitor leads to hepatic inflammation and
fibrogenesis via an NADPH oxidase 2 (NOX2)-dependent pathway in NAFLD. Results
showed that microcystin (MC) administration, a potent PP2A inhibitor found in
environmental exposure, led to an exacerbation of NAFLD pathology with increased CD68

10

immunoreactivity, the release of proinflammatory cytokines, and stellate cell activation, a
process that was attenuated in mice that lacked the p47phox gene and miR21 knockout
mice. Mechanistically, leptin-primed immortalized Kupffer cells (a mimicked model for
an NAFLD condition) treated with apocynin or nitrone spin trap 5,5 dimethyl-1- pyrroline
N-oxide (DMPO) had significantly decreased CD68 and decreased miR21 and α-smooth
muscle actin levels, suggesting the role of NOX2-dependent reactive oxygen species in
miR21-induced Kupffer cell activation and stellate cell pathology. Furthermore, NOX2dependent peroxynitrite generation was primarily responsible for cellular events observed
following MC exposure since incubation with phenylboronic acid attenuated miR21 levels,
Kupffer cell activation, and inflammatory cytokine release. Furthermore, blocking of the
AKT pathway attenuated PP2A inhibitor-induced NOX2 activation and miR21
upregulation. Taken together, we show that PP2A may have protective roles, and its
inhibition exacerbates NAFLD pathology via activating NOX2-dependent peroxynitrite
generation, thus increasing miR21-induced pathology. NEW & NOTEWORTHY Protein
phosphatase 2A inhibition causes nonalcoholic steatohepatitis (NASH) progression via
NADPH oxidase 2. In addition to a novel mechanism of action, we describe a new tool to
describe NASH histopathology.
2.1 INTRODUCTION
Nonalcoholic Fatty liver disease (NAFLD), a silent liver disease, has recently
become an imperative public health concern because of its high prevalence, high risk of
progression to severe liver illnesses, and strong association with environmental and genetic
factors [6, 61]. Nonalcoholic steatohepatitis (NASH) progression is believed to be
governed by a multihit paradigm. Earlier studies have shown that oxidative stress resulting
11

from exposure to environmental contaminants and/or their metabolites act as a “second hit”
or “multiple hits” to exacerbate NAFLD to NASH pathophysiology [6, 8]. The “first hit”
includes leptin resistance or insulin resistance, which might stimulate fat accumulation in
the liver (steatosis). The second hit generally involves oxidative stress and/or cytokines
that result in Kupffer cell and stellate cell activation, proinflammatory response, and
fibrogenesis.

Environmental contaminants have been shown to act as a second hit in NAFLD for
its progression to NASH and liver fibrosis. Recent incidences of higher cyanobacterial
blooms that have been shown to release and concomitantly expose individuals to protein
phosphatase 2A (PP2A) inhibitors like microcystin (MC) can be a significant threat to
NAFLD patients of all ages. MC exposure through these cyanobacterial blooms can act as
a second hit or may combine with other underlying factors such as insulin and leptin
resistance and lipotoxicity, as found in morbid obesity to advance into severe liver disease
from a primarily benign steatotic condition. MC is an emerging drinking water contaminant
and imposes global health concern [62]. Preventing MC-induced liver injury is crucial to
understand the molecular mechanism behind the toxicity of MC [63]. Recent studies
largely focus on MC-induced oxidative stress, apoptosis, and oncotic necrosis as a cause
of liver injury [63-66]. MC exposure also has been associated with increased incidences of
liver cancer [67]. Though the environmental impact of MC remains alarming, it is too early
to predict that exposures from such PP2A inhibitors might be one of the causes for NAFLD
progression to NASH. PP2A consists of a large family of Ser/Thr phosphatases, consisting
of a catalytic C subunit and a structural A subunit that is widely bound to a regulatory Btype subunit [37]. The B-type subunits determine the function and modulation of PP2A
12

trimers, but despite their importance in physiology, their roles in controlling vital pathology
processes in the liver remain under investigated [37]. Conditional knockouts (KOs) of this
gene, specifically in the liver in the C57BL6 background, result in less lipid deposition in
the liver (decreased steatosis) [68]. The role of steatosis in NAFLD pathology remains an
area of intense scrutiny. With PP2A inhibition leading to less steatosis, previous studies
concerning loss of liver fat and its association with inflammation in the liver might provide
some insight into the role of PP2A in NAFLD, especially if it is inhibited by an
environmental factor like MC. Earlier studies, including ours, have shown that the potential
sources of oxidative stress include xanthine oxidase (XDH) [30], electron transport chain
enzymes, liver cytochrome P450–2E1 (CYP2E1) [31], and catalytic subunit of NADPH
oxidase (or NOX) [32]. We and others have previously shown that NADPH oxidase 2
(NOX2)-induced peroxynitrite produces a stable nitrated tyrosine residue on proteins [3nitrotyrosine (3NT)] in NAFLD. Indeed, 3NT is being considered as an established
biomarker of oxidative stress in both an in vitro and an in vivo model of oxidative stress
[69]. Even though peroxynitrite was discovered decades ago, the mechanism of reactive
oxygen species (ROS) signaling in progressive NAFLD remains unclear, especially the
route of its activation by exogenous triggers and its downstream signaling that links
inflammatory pathways.

NOX2- mediated redox signaling can activate micro RNAs. Previous studies have
shown the role of microRNAs (miR21) in disease pathology over the past decade. miRNAs
are small (18~25 nucleotides long), endogenous, noncoding RNA molecules that regulate
gene expression at the transcriptional level [70, 71]. Most recently we and several research
groups have shown that microRNA 21 (miR21) is one of the most upregulated microRNAs
13

in NAFLD and NAFLD-associated kidney inflammation [57, 72, 73]. miR21 was shown
to regulate the SMAD pathway in NAFLD fibrogenesis [57]. Since both ROS and miR21
are dysregulated in progressive NAFLD, it is important to understand the crosstalk between
the external triggers and upstream and downstream pathways of NOX2-induced miR21
activation. Justifiably, since numerous studies have shown that NOX2 activation is
regulated by environmental triggers which act as second hits, mechanistically, we chose to
investigate whether MC, a toxin produced from cyanobacteria in harmful algal blooms and
a known PP2A inhibitor [51], activated an NOX2-miR21 signaling pathway and
exacerbated NASH pathogenesis.

2.2 MATERIALS AND METHODS

Materials:
All other chemicals were of analytical grade and were purchased from Sigma
Chemical Company unless otherwise specified. MC-LR was purchased from Cayman (Ann
Arbor, MI); leptin was purchased from BioVision (Milpitas, CA); LB-100, the PP2A
inhibitor, was purchased from MedKoo; and wild-type and gene-specific KO mice,
including P47 phox KO and miR21 KO mice, were purchased from Jackson Laboratories
(Bar Harbor, ME). Animal diets were purchased from Research Diets (New Brunswick,
NJ). Anti-3NT, anti-CD68, anti-GP91 phox, anti-P47 phox, and anti-α-smooth muscle
actin (SMA) primary antibodies were purchased from Abcam (Cambridge, MA). AntiP65 and anti-p-AKT were purchased from Santa Cruz Biotechnology (Dallas, TX).
Species-specific biotinylated-conjugated secondary antibody and streptavidin-horseradish
peroxidase were purchased from Vector Laboratories (Vectastain Elite ABC kit,
14

Burlingame, CA). Fluorescence-conjugated (Alexa Fluor) secondary antibodies and
ProLong Gold antifade mounting media with DAPI were bought from Thermo Fisher
Scientific (Waltham, MA).
Mouse Model:
Diet-induced NAFLD model:
Pathogen-free adult male mice with C57BL/6J background (Jackson Laboratories)
were used in the study. They were fed with a high-fat (60% kcal) supplemented
methionine-choline-deficient (MCD-HFD) diet, (Research Diets) for 8 wk to induce
NAFLD, whereas mice kept on a normal chow diet were used as a lean control. Mice that
contained the disrupted P47 phox gene (B6(cg)-Ncf1M1J/J(JAC004742) and disrupted
miR21 gene (B6.129S6-Mir21tm1 Yoli/J) (Jackson Laboratories) were also fed an MCDHFD and were treated identically to the NAFLD mouse model. All mice were housed with
3–5 mice/cage at 23°C–24°C on a 12:12-h light-dark cycle with ad libitum access to food
and water. All animals were treated in strict accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals, and the experiments were
approved by the institutional review board at the University of South Carolina at Columbia.
Induction of liver injury and exposure to environmental toxin MC:
Wild-type, as well as gene-specific KO mice, at 6 wk were administered with
vehicle (ethanol in PBS), MC-LR (MC-LR) (10 µg/kg, 5 dosages/wk), through the
intraperitoneal route for 2 wk. A set of MCD-HFD-fed mice (NAFLD model) was not
injected with MC-LR in this study. On completion of treatment, mice were euthanized, and
serum or liver tissue was collected for further processing.
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Kupffer Cell Culture and Treatments:
Immortalized rat Kupffer cell line (SV40) was grown and maintained in complete
DMEM. The media was supplemented with 10% FBS (Atlanta Biologicals; Norcross, GA),
2 mM glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco; Grand Island,
NY) at 37°C in a humidified atmosphere of 5% CO2. Cells were serum starved (DMEM
with 1% FBS) overnight before cells were given any treatment. The cells were then treated
with vehicle (control) or 100 ng/mL leptin (BioVision), MC-LR (20 μM), or PP2A
inhibitor (5 µM). Other groups of cells were incubated with leptin, MC, or PP2A inhibitor
in combination with 100 μM apocynin (Apo) (Sigma-Aldrich), an inhibitor of NADPH
oxidase activity, and thus preventing production of superoxide, 100 μM phenyl boronic
acid (FBA), was used as a scavenger for 100 mM peroxynitrite, the spin trap DMPO
(Alexis Biochemical, San Diego, CA), 20 µM miR21 inhibitor (Qiagen; Valencia, CA),
and AKTi [50 µM phosphatidylinositol 3-kinase inhibitor (LY294002) (AKTi)]. The cells
were then lysed in TRIzol (Invitrogen; Grand Island, NY) for mRNA as well miRNA
extraction or plated on coverslips (MatTek; Ashland, MA) for immunofluorescence
staining after completion of the treatment.
Stellate Cell Culture and Treatments:
An immortalized rat hepatic stellate cell line (8B), kindly provided to us by Dr.
Anna Mae Diehl (Duke-Gastroenterology), was maintained in high-glucose DMEM
(Corning, Tewksbury, MA) supplemented with 10% FBS (Atlanta Biologicals), 2 mM
glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin (Gibco) at 37°C in a
humidified atmosphere of 5% CO2. The cells were then treated as Kupffer cells
(see Kupffer Cell Culture and Treatments). After treatments, the cells were lysed in TRIzol
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(Invitrogen) for mRNA or plated on coverslips (MatTek Corp) for immunofluorescence
staining after completion of the treatment.
Histopathology and Digital Imaging Analysis of NAFLD:
Sections of liver tissue from each mouse were collected and fixed in 10% neutral
buffered formalin. These formalin-fixed, paraffin-embedded tissues were cut into 5-μm
thick sections. For histological examinations, formalin-fixed liver sections were stained
with hematoxylin-eosin by the Instrumentation Resource Facility, University of South
Carolina School of Medicine, and observed under the light microscope. For the quantitative
analysis of NAFLD, liver slices were scanned at ×20 using a NanoZoomer-SQ
(Hamamatsu Corporation, Hamamatsu, Japan), and digital images of entire liver sections
were captured at ×20x (pixel size: 0.452 µm) using NDPview 2 software (Hamamatsu,
Japan). Steatosis, fibrosis, and liver tissue density were automatically assessed from the
same entire liver sections stained with picrosirius red, using Biocellvia’s image processing
software program. The liver steatosis was defined by the steatosis area index, which
corresponds, for a liver section, to the ratio of the total surface of vesicles (diameter >5
µm) versus the total surface of the liver section, expressed in percent. The liver fibrosis
was defined, for a liver section, as the ratio of the area of stained collagen fibers versus the
total area of the liver section, expressed in percent. The liver tissue density was assessed
automatically from the mean density value of thousands of microtiles overlaying the entire
liver sections and previously detailed for the pulmonary tissue density [74].
Immunohistochemistry:
The liver sections were deparaffinized using a standard protocol. Briefly, sections
were incubated with xylene twice for 3 min, washed with xylene-ethanol (1:1) for 3 min,
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rehydrated through a series of ethanol (twice with 100%, 95%, 70%, and 50%) twice with
distilled water, and finally rinsed twice with PBS (Sigma-Aldrich). Antigen epitope
retrieval of the deparaffinized sections was performed using epitope retrieval solution and
steamer (IHC World, Woodstock, MD) for 45 min. H2O2 (3%) was used for 5 min to block
the endogenous peroxidases. The primary antibody for CD68 (1:300, ab125212, Abcam),
α-SMA (1:250, ab32575, Abcam), 3NT (1:250, ab110282, Abcam), P-65 (1:300, SC-8008,
Santa Cruz Biotechnology), and p-AKT (1:300, SC-293125, Santa Cruz Biotechnology)
were used overnight in recommended dilutions. Species-specific biotinylated-conjugated
secondary antibody and streptavidin conjugated with horseradish peroxidase were used to
perform antigen-specific immunohistochemistry according to the manufacturer’s standard
protocols. 3,3′ diaminobenzidine (Sigma-Aldrich) was used as a chromogenic substrate.
Tissue sections were counterstained with Mayer’s hematoxylin (Sigma-Aldrich).
Phosphate-buffered saline was used for washing three times between the steps. Sections
were finally mounted in Simpo mount (GBI Laboratories, Mukilteo, WA) and observed
under a ×20 objective using an Olympus BX51 microscope (Olympus, America).
Morphometric analysis was done using CellSens Software from Olympus America (Center
Valley, PA).
Immunofluorescence Microscopy:
In vivo, formalin-fixed, paraffin-embedded liver tissue sections were subjected to
deparaffinization according to standard instructions. Epitope retrieval of the deparaffinized
sections was done with an epitope retrieval solution and steamer (IHC World) according
to the manufacturer's protocol. The primary antibodies anti-GP-91 phox (SC-5827) and
anti-p47 phox (SC-17845) were used at recommended dilutions at 1:300. Species-specific
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anti-IgG secondary antibodies conjugated with Alexa Fluor 633 or 488 (Invitrogen) were
used. The sections were mounted in a ProLong Gold antifade reagent with DAPI (Life
Technologies, Carlsbad, CA). Images were taken under ×20, ×40, and ×60 magnification
with an Olympus BX51 microscope.
In vitro, after completion of the treatments under serum-starved conditions as in
cell culture, cells attached on coverslips were fixed with 10% neutral buffered saline. After
the cells were washed with PBS containing 0.1% Triton X (Sigma), they were blocked with
3% BSA, 0.2% Tween (Fisher), and 10% FBS in PBS. Cells were incubated with primary
antibodies, anti- α-SMA (ab32575) and anti-3NT (ab110282) (Abcam), and were used at
1:250 dilution, followed by species-specific secondary antibody conjugated with Alexa
Fluor 633 or 488. The stained cells attached on the coverslips were mounted on slides with
ProLong Gold antifade reagent with DAPI (Life Technologies) and viewed under ×40 and
×60 magnification with an Olympus BX51 microscope.
Serum Alanine Aminotransferase:
Serum alanine aminotransferase (ALT) levels were quantified using an automated
analyzer at the University of Georgia Clinical pathology core facility.
Quantitative Real-Time Polymerase Chain Reaction:
Gene expression (mRNA and miRNA) levels from mice liver tissue and the
immortalized rat hepatic stellate cell line (8B) were measured by quantitative real-time
reverse transcription-polymerase chain reaction (qRT-PCR) by following our routine
laboratory protocol. The primers used for RT-PCR in 5′ to 3′ orientations are provided
in Table 2.1.
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Table 2.1. Primer sequences for the different target genes.
Gene

Primer sequence

CD68

Forward: GCTACATGGCGGTGGAGTACAA

(Mouse)

Reverse: ATGATGAGAGGCAGCAAGATGG

MCP-1

Forward: CACAGTTGCCGGCTGGAGCAT

(Mouse)

Reverse: GTAGCAGCAGGTGAGTGGGGC

TNF-α

Sense: CAACGCCCTCCTGGCCAACG

(Mouse)

Antisense: TCGGGGCAGCCTTGTCCCTT

IL-1β

Sense: CCTCGGCCAAGACAGGTCGC

(Mouse)

Antisense: TGCCCATCAGAGGCAAGGAGGA

p47 phox

Sense: GGTCGACCATCCGCAACGCA

(Mouse)

Antisense: TGTGCCATCCGTGCTCAGCG

RelA

Sense:TAGGTCCTTTTGCGCTTCTC

(Mouse)

Antisense:GCTCCTGTTCGAGTCTCCAT

P65

Sense: CAAGTGCCTTAATAGCAGGGCAAA

(Mouse)

Antisense: AGAGCTAGAAAGAGCAAGAGTCCAAT

NFkβ1_P105

Sense: GAACGATAACCTTTGCAGGC

(Mouse)

Antisense: ATTTCGATTCCGCTATGTGTG

PP2AR1

Sense: CAACCTGGATTGTGTGAACG

(Mouse)

Antisense: AATTCCACACCAAGCTGTCC

PP2AC1

Sense: TACTCCGAGGGAATCACGAG

(Mouse)

Antisense: TCGGATGTGATCCAGTGTGT

20

PP2AR5D

Sense: CCCCAGATTGTCAAGAAGGA

(Human)

Antisense: CTGAGTGGGTCTGACACGAA

PP2ACB

Sense: CCCTGGATCGTTTACAGGAA

(Human)

Antisense: TGGGTGCACTGAAAATGGTA

Western Blot Analysis:
Each liver protein lysate (25 μg each) was resolved on 4%–12% bis-Tris gradient
gel (Invitrogen). Resolved protein bands were transferred (semidry) to nitrocellulose
membrane using the Trans-Blot Turbo transfer system (Bio-Rad Laboratories, Hercules,
CA). Primary antibodies P65 (SC-8008, Santa Cruz Biotechnology), AKT and p-AKT
(9272 and 4060, respectively, Cell Signaling Technology), and PP2A (ab32065, Abcam)
were used at recommended dilutions (1:500), as well as β-actin used at 1:1,000, and
compatible horseradish peroxidase-conjugated species-specific secondary antibodies were
used at 1:5,000 dilutions. Pierce ECL Western Blotting Substrate (Thermo Fisher
Scientific, Rockford, IL) was used for detection. The blot was imaged using G:BoxChemi
XX6 (Syngene Imaging Systems) and subjected to densitometry analysis using Image J.
Estimation of Nitric Oxide:
Nitric oxide (NO) was estimated by measuring total nitrite formation in freshly
harvested cell culture fluids using the Griess Reagent system (Promega, Madison, WI)
according to the manufacturer’s standard protocols.
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Statistical Analyses
All in vivo experiments were repeated three times with at least 3 mice per group
(n = 3; data from each group of 3 mice were pooled). All in vitro experiments were repeated
at least 3 times (n = 3). The statistical analysis was carried out by unpaired t-test and
ANOVA. For all analyses, P < 0.05 was considered statistically significant.

2.3 RESULTS

Exogenous PP2A inhibitor exacerbates NAFLD pathology

We and others have shown that environmental contaminants and their metabolites
act as a second hit to exacerbate NAFLD pathophysiology [6, 8]. To study the role of MCLR, an exogenous PP2A inhibitor in exacerbating NASH, we used MCD-HFD-fed mice to
induce NAFLD, followed by a low, chronic dose of MC (NAFLD + MC). The NAFLD +
MC mice showed a marked increase in NASH pathophysiology, as shown by increased
infiltrating immune cells (inflammation), hepatocytes with bipolar nuclei, and ballooning
when compared with NAFLD control mice alone or lean mice exposed to MC (lean + MC)
(Fig.2.1 A). Liver tissues were analyzed next for steatosis and fibrosis status by picrosirius
red staining. NAFLD + MC liver showed significantly increased sinusoidal and bridging
fibrosis as compared with NAFLD, lean, or lean + MC mice (P < 0.001) (Fig.2.1, B and F).
NAFLD + MC mice also showed decreased total steatosis area (Fig.2. 1D) and mean
vesicle size (Fig.2.1E) when compared with NAFLD mice (P < 0.001). However, the tissue
density of NAFLD + MC mice liver was improved when compared with NAFLD mice
alone (P < 0.001) (Fig.2.1G). In addition, the NAFLD + MC mice group showed increased
NASH CRN score with increased lobular inflammation, hepatocyte ballooning, and
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fibrosis when compared with both NAFLD control mice and lean + MC mice (Table 2.2).
Serum ALT levels were increased in both lean and NAFLD mice exposed to MC as
compared with either lean mice or NAFLD control mice, respectively (Fig.2.1C).We
analyzed the mRNA expression of the two subunits of PP2A, namely PP2AR and PP2AC,
in the murine liver. We observed that there was a significant increase in the PP2AR and
PP2AC subunits in the NAFLD + MC group compared with the lean or lean + MC group
in the mouse liver (*P < 0.05) (Fig.2.1, J and K). A similar significant increase
in PP2AR and PP2AC was observed in the human NASH liver compared with the human
control liver (*P < 0.05) (Fig.2.1, N and O). We used Western blot analysis to analyze the
protein levels of PP2A, and our results showed an increased expression of PP2A in the
NAFLD and NAFLD + MC (*P < 0.05) groups compared with the lean mouse control
(Fig.2.1, H and I), though there was a decrease in the PP2A protein expression in the
NASH group compared with the control group in human (Fig.2. 1, L and M). These results
clearly showed that the exposure to exogenous PP2A inhibitor was significantly affecting
the activity rather than the levels in the mouse liver.

Table 2.2. NASH CRN (clinical research network score)
Characteristics

Lean
Control

Steatosis
Lobular
inflammation
Hepatocyte
Ballooning
Stage of fibrosis

0
0

Lean
Control
+MC
0
1

0
0
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NAFLD NAFLD+
MC
3
1

2
2

0

1

2

1A

1C

2

Activation of Kupffer cells and hepatic stellate cells in an underlying NAFLD
condition by exogenous PP2A inhibitor MC.
Liver inflammation and fibrosis are the two major stages of NASH pathogenesis
[75]. These two stages are regulated by liver-specific cell types such as resident
macrophages or Kupffer cells and hepatic stellate cells. To investigate whether MC
activated both Kupffer cells and hepatic stellate cells, immunoreactivities of Kupffer cell
activation marker CD68, CD11b, and hepatic stellate cell activation marker α-SMA were
analyzed in liver slices. Results showed that there was a significant increase in CD68 as
well as CD11b immunoreactivity in NAFLD + MC mice as compared with NAFLD alone
or lean + MC groups of mice (P < 0.001) (Fig.2.2, A, C, D, and F). Similarly, α-SMA
immunoreactivity, a hallmark of stellate cell activation, was significantly increased in
NAFLD + MC mice groups when compared with NAFLD mice or the lean + MC mice
group (P < 0.001) (Fig.2.2, B and E). These results were further confirmed at mRNA level.
CD68 mRNA expression was significantly increased in NAFLD + MC groups when
compared with NAFLD mice or lean + MC mice alone (P = 0.018 and P = 0.012,
respectively) (Fig.2.2, I). The above results suggested that in an underlying condition of
NAFLD, exposure to an exogenous PP2A inhibitor activated Kupffer cells and hepatic
stellate cells, and the resultant activation of these cell types could generate a
proinflammatory and fibrotic phenotype. To assess that the Kupffer cell activation
participated in a proinflammatory phenotype, mRNA expression of proinflammatory
cytokines such as monocyte-chemoattractant protein-1 (MCP-1, CCL2) and tumor necrosis
factor-α (TNF-α) were examined. The result showed that there was a significant increase
in both CCL2 and TNF-αmRNA expression in NAFLD + MC mice when compared with
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NAFLD and lean + MC mice (P < 0.001) (Fig.2.2, G and H). The above results thus
suggested that an exogenous PP2A inhibitor exposure in NAFLD induced proinflammatory
responses via CCL2 and TNF-α.
Exogenous PP2A inhibitor MC induces NOX2-dependent oxidative stress in NASH
pathogenesis.
To study whether MC synergized NOX2 activation in NASH progression,
immunostaining of both the membrane subunit (GP91 phox) and cytoplasmic subunit (p47
phox) of NOX2 was performed. Results showed that the colocalization events of both
subunits were significantly increased in NAFLD + MC mice as compared with NAFLD
mice or lean + MC mice alone (P = 0.015 and P < 0.001, respectively) (Fig.2. 3, A and C).
The mRNA expression of p47 phox was significantly increased in NAFLD + MC mice as
compared with NAFLD mice or lean + MC mice alone (Fig.2.3,D). Interestingly, lean mice
exposed with MC (lean + MC) showed a significant increase in p47 phox mRNA
expression as compared with lean mice alone (P < 0.001) (Fig.2.3, D) but did not show
significant increase in GP91 phox-p47 phox colocalization events (Fig.2.3, A and C).
There are significant colocalization events for CD68 and GP91 phox subunits in NAFLD
+ MC mice when compared with the NAFLD group as well as the other groups (Fig.2.3,
B). CD68 is the marker for the activated Kuppfer cells in the liver, and colocalization
of GP91 phox with CD68 suggests that NOX2 is activated in the Kuppfer cells. The result
suggested that MC exacerbated NOX2 activation in an underlying condition of NAFLD.
Furthermore, to investigate the role NOX2 in peroxynitrite generation and subsequent
NASH progression, we used P47 phox gene-deleted mice (P47phox KO) fed with an
MCD-HFD

and

exposed

them

to

the
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exogenous

PP2A

inhibitor.

The

immunohistochemistry of 3NT, a marker of peroxynitrite-induced oxidative stress, Kupffer
cell activation marker CD68, CD11b, and stellate cell activation marker (α-SMA) was
performed. Results showed that there was an increased immunoreactivity of 3NT in
NAFLD + MC mice when compared with NAFLD mice alone, whereas there was a
significant decrease in p47 phox KO mice groups exposed with MC (P = 0.013)
(Fig.2.3, E and I). These results suggested that the peroxynitrite-induced oxidative stress
as a result of PP2A inhibition exacerbated NASH and was NOX2 dependent. Results also
showed increased immunoreactivity of CD68, CD11b, and α-SMA in NAFLD + MC mice
groups as compared with NAFLD alone, whereas there was a significant decrease in P47
phox KO mice groups (P < 0.001) (Fig.2.3, F–H and J–L). The mRNA expression of
proinflammatory cytokines CD68, CCl2, and TNF-α showed a significant increase in
NAFLD + MC mice groups, whereas a decrease in P47 phox KO mice was observed
(Fig.2.3, M). The data suggested that the exogenous PP2A inhibitor activated Kupffer and
stellate cells, increased inflammation, and were primarily NOX2 dependent.
Exogenous PP2A inhibitor MC synergistically increases NOX2 activation and
tyrosine nitration in Kupffer cells.
Recent studies have shown that activated NOX2 generates ROS in microglia and
macrophages in traumatic brain injury [76] and is the primary source of oxidative stress in
macrophages [77, 78]. To study whether MC generated NOX2-dependent oxidative stress
via a free radical mechanism in hepatic resident macrophages, leptin-primed Kupffer cells
(leptin resistance condition of NAFLD) were exposed to MC. Results showed a significant
increase in GP91 phox-p47 phox colocalization events in leptin + MC-exposed Kupffer
cells as compared with vehicle control (control) or leptin-primed control cells (leptin) or
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MC-treated cells (P < 0.001, P = 0.04, and P = 0.018, respectively) (Fig.2.4, A, i–
v and 2.4, B). However, leptin-primed cells treated with Apo (a nonspecific inhibitor of
NADPH oxidase) and exposed to MC showed a significant decrease in GP91 phox-p47
phox colocalization events as compared with leptin + MC group cells (P < 0.001) (Fig.2.4,
A,iv and v, and 2.4, B). Interestingly, leptin-primed Kupffer cells exposed with MC
showed a significant increase in 3NT immunoreactivity when compared with either vehicle
control (control), leptin-primed, or MC-treated cells. In addition, leptin-primed cells
exposed to MC and either Apo, DMPO (free radical spin trap), or FBA (peroxynitrite
scavenger) showed a significant decrease in 3NT immunoreactivity (Fig.2.5, A and B).
The above data suggested that in exogenous PP2A inhibitor-induced NASH, Kupffer cells
might be the major cellular site for NOX2-dependent ROS generation.
Exogenous PP2A inhibitor-induced NOX2 triggers miR21-dependent NF-κB
pathway activation in NASH.
NOX2 plays a significant role in regulating noncoding, small miRNAs. We and
others have shown previously that NOX2 positively regulates miR21 in renal inflammation
and lung cancer [72, 79]. To study whether NOX2-mediated oxidative stress triggered by
a prior expression of an exogenous PP2A inhibitor can activate an miR21 signaling
pathway in progressive NASH, its expression was analyzed by qRT-PCR in liver tissue.
Results showed that there was a significant increase in miR21 expression in NAFLD + MC
mice as compared with NAFLD control mice (P < 0.001) (Fig.2.6, A). However, P47
phox KO mice exposed with MC showed a significant decrease in miR21 expression in
liver tissue (P = 0.04) (Fig.2.6, A). The data clearly suggested that miR21 expression was
NOX2 dependent in MC-triggered NASH pathology. Furthermore, we studied the role of
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miR21 in NASH pathogenesis. We used miR21 gene-deleted mice (miR21 KO) exposed
to MC followed by the analysis of Kupffer cell pathology, stellate cell activation, and
proinflammatory cytokine expression. Results showed a significant increase in
CD68, CCL2, and TNF-αmRNA expression (P > 0.01) (Fig.2.6, B). Interestingly, miR21
KO mice showed a significant decrease in CD68, CCL2, and TNF-α (P < 0.001) (Fig.2. 6,
B). Results showed that there was a significant increase in CD68, CD11b (P = 0.002
and P = 0.003, respectively) (Fig.2.6, C, E, F, and H) and α-SMA (P < 0.001) (Fig.2.
6, D and G) in NAFLD + MC mice when compared with NAFLD control mice alone.
Interestingly, miR21 KO mice exposed with MC showed a significant decrease in CD68,
CD11b, and α-SMA immunoreactivity (P < 0.001) (Fig.2.6, C–H) as compared with
NAFLD + MC mice. The above data suggested that NOX2-induced miR21 plays a
significant role in Kupffer cells and stellate cell activation leading to a proinflammatory
phenotype in NASH.
To study whether miR21 acted downstream by modulating the p-AKT-NF-κB
signaling pathway, we analyzed the immunoreactivity as well as protein expression levels
by Western blot analysis technique of the various components of the above pathway.
Results showed that there was a significantly increased immunoreactivity of p-AKT and
the p65 subunit of NF-κB in NAFLD + MC mice liver when compared with the NAFLDonly liver (P = 0.002 and P = 0.005, respectively) (Fig.2.7, A–D) as well as in the Western
blot analysis (P < 0.001 and P < 0.001, respectively) (Fig.2.7, F–H). miR21 KO mice
exposed to MC showed a significant decrease in p-AKT and p65 immunoreactivity (P <
0.001 and P = 0.002, respectively) (Fig.2.7, A–D) as well as in the Western blot analysis
(P < 0.001 and P = 0.005, respectively) (Fig.2.7, F–H). We also conducted mRNA
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expression of the NF-κB subfamily gene such as RelA, p65, and NF-κB1 (P105). Results
showed that mRNA expression of RelA and P65 were significantly increased in these
genes in NAFLD + MC mice (P < 0.001 and P < 0.001, respectively), whereas miR21 KO
mice showed decreased expression of P65 gene in comparison with NAFLD only (P <
0.001) (Fig.2.7, E). NF-κB-p105 subfamily showed similar increased expression patterns
in the NAFLD + MC group and a subsequently decreased expression in miR21 KO mice,
but the change was not significant (Fig.2.7, E). The above data suggested that miR21 not
only increased the activity of NF-κB but also increased transcription of NF-κB family
genes.
To reconfirm the mechanisms in vitro, NOX2-miR21-NF-κB signaling pathway
was examined in immortalized rat Kupffer cells. The Kupffer cells were primed with leptin
and exposed to MC alone or together with NOX2 inhibitor, DMPO (free radical scavenger),
FBA (peroxynitrite inhibitor), and miR21 inhibitor (miR21 inh). The results showed a
significant increase in miR21 expression in leptin-primed Kupffer cells exposed with MC
(leptin + MC) when compared with leptin alone, MC alone, or vehicle control (P < 0.05)
(Fig.2.8, A). Leptin-primed cells coexposed with MC and either Apo or FBA showed a
significant decrease in miR21 expression (P < 0.05) (Fig.2.8, A). These data showed that
miR21 expression was mediated by NOX2-dependent oxidative stress and was primarily
in Kupffer cells. We used immunofluorescence staining to understand whether this NOX2mediated miR21 expression caused Kupffer cell activation. Results showed that there was
a significant increase in the immunoreactivity of CD68 in the leptin-primed cells exposed
with MC as compared with vehicle control, leptin-, or MC-treated cells (Fig.2.8,B, i–
iv, 2.8, C, iii–iv, and 2.8, D). Interestingly, leptin-primed cells cotreated with MC and Apo,
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DMPO, FBA, and miR21 inh showed a significant decrease in CD68 immunoreactivity
(Fig.2.8, B, v–viii and 2.8, D). The above results suggested a strong role of NOX2-miR21NF-κB pathway in the activation of Kupffer cells.
Exogenous PP2A inhibitor MC increases M1 phenotype in Kupffer cells via NOX2miR21-dependent pathway.
Kupffer cells (resident liver macrophages) play a significant role in liver
immunology. M1 phenotype of Kupffer cells is characterized by the release of high levels
of proinflammatory cytokines [80], adaptation to an elongated morphology [81], activation
of inducible nitric oxide synthase (iNOS), and release of NO [82]. We performed
immunofluorescence imaging of β-tubulin for assessment of altered morphology, iNOS,
and measured the NO release from Kupffer cells. Leptin-primed Kupffer cells exposed
with MC showed an elongated morphology (Fig.2.9, A, iii), increased iNOS expression
(Fig.2.9, B, iii), and NO release (Fig.2.9, C) as compared with control, leptin, or MC
exposed alone. However, Kupffer cells coexposed with Apo, DMPO, miR21 inhibitor, or
FBA showed normal cell morphology (Fig.2.9, A, v–viii), decreased iNOS expression
(Fig.2.9, B, v–viii), and NO release (P < 0.05) (Fig.2.9, C). The above results suggested
that MC-mediated NOX2-miR21 axis modulated the M1 phenotype of Kupffer cells and
generated subsequent proinflammatory response.
Exogenous PP2A inhibitor-induced NOX2 and ROS activates hepatic stellate cells.
To show the exogenous PP2A inhibitor-induced profibrogenic signaling in
NAFLD, we studied the hedgehog signaling mechanisms in an in vitro setup. Leptinprimed and MC-treated hepatic stellate cells were coexposed with Apo, DMPO, miR21
inhibitor, and FBA to test the role of NOX2 mediators or miR21 in liver fibrosis.
30

Immunofluorescence images of α-SMA (stellate cell activation marker) showed a
significant increase in leptin-primed stellate cells exposed with MC when compared with
control, leptin, and MC alone groups (P < 0.001) (Fig.2.10, A, i–iv and 2.10, B).
Interestingly, the cells coexposed with Apo, DMPO, FBA, and miR21 inh showed
significant decreases in α-SMA immunoreactivity as compared with leptin-primed cells
exposed with MC (P < 0.001) (Fig.2.10, A, iv–viii and 2.10, B). Results also suggested that
activation of stellate cells were mediated by MC-induced NOX2 and oxidative stress
instead of the NOX2-miR21 axis.
Exogenous PP2A inhibitor MC activates NOX2 via AKT pathway.
To show the mechanistic link between the exogenous PP2A inhibitor and its
subsequent activation of NOX2 both in vivo and in vitro, we conducted experiments in
immortalized Kupffer cells. Leptin-primed cells were incubated with either MC, a standard
PP2A inhibitor, or an AKT inhibitor. Results showed that MC alone or leptin-primed MC
groups had a significant increase in NOX2 activation (P < 0.05) (Fig.2.11, A–D). A
standard PP2A inhibitor also mimicked the results obtained by MC. Interestingly, AKT
inhibitor treatment in both leptin-primed MC or PP2A inhibitor groups showed a
significant decrease in the NOX2 activation, suggesting that NOX2 activation was
primarily due to the AKT pathway (P < 0.05) (Fig.2.11, A–D). Since NOX2-derived
peroxynitrite was paramount to the NASH pathology caused by exogenous PP2A inhibitor,
we analyzed whether the AKT pathway was important for the generation of NOX2-induced
ROS. Results showed that MC alone or leptin-primed MC groups had a significant increase
in peroxynitrite generation as exhibited by 3NT levels (P < 0.05) (Fig.2.12, A–D). A
standard PP2A inhibitor also mimicked the results obtained by MC. Interestingly, AKT
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inhibitor treatment in both leptin-primed MC or PP2A inhibitor groups showed a
significant decrease in the 3NT levels, suggesting that NOX2 activation-induced
peroxynitrite generation was primarily due to the AKT pathway (P < 0.05) (Fig.2.12, A–
D). A mechanistic summary of the study has been provided in (Fig.2.13).
2.4 DISCUSSION
Our studies indicate for the first time, to the best of our knowledge, the role of
exogenous PP2A inhibitors in exacerbating NAFLD pathology and provide a mechanistic
basis of advancing the progression of NAFLD via NOX2-mediated miR21 (Fig.2.13). The
results reported herein show that the administration of MC-LR, a proven environmental
hepatotoxin and a PP2A inhibitor, caused increased inflammation, increased activation of
stellate cells, and advanced fibrotic lesions in NAFLD. Furthermore, the results showed a
decreased hepatic steatosis concomitant to the progression of liver injury as indicated by
increased serum ALT levels. Our novel histological assessment tool developed by our
collaborators at Biocellvia also showed a significant increase in fibrosis area in the liver,
which was subjected to exogenous PP2A inhibitor administration.
We and others have shown previously that NOX2 plays a significant role in
promoting NASH and its fibrotic pattern. To understand the role of exogenous PP2A
inhibition and its relationship with NASH pathogenesis, we studied the activation of
NOX2. Our results of increased NOX2 activation following inhibition of PP2A and
subsequent increases in protein levels of macrophage activation marker CD68 and stellate
cell activation marker α-SMA while attenuation of all the above markers in p47 phox KO
mice suggested that PP2A inhibition induced a strong NOX2 activation both in vivo and
in vitro. Strikingly, PP2A-induced NOX2 activation and its downstream association with
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inflammation and extracellular matrix deposition were also associated with increased
levels of miR21. Interestingly our results showed an increase in PP2A protein levels
following MC administration in mice, whereas human NASH samples showed a decrease
in the same protein. Since PP2A inhibition is an enzymatic process, it is clear from our
results that the activity of the protein is more relevant for the pathology rather than the
levels of the same protein in the liver.
Studies show that miR21 has a prominent role in NAFLD fibrosis, and NOX2induced downstream signaling through peroxynitrite generation can induce miR21
expression [57]. Our results of increased levels of miR21 both in vivo and in vitro and its
restricted levels in the presence of either a gene deletion of NOX2 cytoplasmic subunit
(p47 phox KO mice) or Apo confirmed such a hypothesis. In addition, in vitro results using
peroxynitrite scavenger FBA showed a decrease in miR21 levels, suggesting strongly that
NOX2-derived peroxynitrite was responsible for the induction of higher miR21 levels in
the liver. The higher miR21 increased liver inflammation via the phosphorylation of AKT
and subsequent activation of NF-κB, a proven pathway for inflammation in the liver and
other organs.
It is widely accepted that liver injury in progressive NAFLD is accompanied by a
parallel decrease in steatosis, and simple hepatic steatosis might be a benign process in the
majority of patients, thus signifying that NASH can be a separate disease with different
pathogenesis [12]. Our report confirms the previous findings by showing a decrease in
mean vesicle size, which is correlative of a subsequent decrease in steatosis area. Studies
show that free fatty acid delivery to the liver and triglyceride accumulation is a prime cause
in liver fat accumulation, and together they may exert protective functions [12]. The above
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fact may be supported by studies that show inhibition of diacyl glycerol acyltransferases
1/2, principal enzymes in triglyceride synthesis in the liver, leads to increased liver injury,
whereas overexpression protects the liver from macrophage activation and their
accumulation in the liver lobule [83, 84]. Interestingly, PP2A plays a significant role in
promoting hepatic steatosis. It does so via positively regulating SREBP1-C, a prime
mediator of hepatic lipogenesis [85]. Thus, inhibiting PP2A in our studies rightly resulted
in decreased steatosis area and the mean vesicle size that correlated strongly with increased
inflammation and fibrosis in an underlying condition of NAFLD. It is also striking that p47
phox-deficient mice and miR21 KO mice in which liver was minimal had higher steatosis
as shown by decreased lipid droplets/vesicle size. The results in these KO mice are very
significant since NASH-associated inflammation has been shown to decrease steatosis, and
both of these genes may represent a yet unidentified metabolic switch that can lead to
reprogramming of liver metabolism in NASH.
Subsequent to miR21-induced inflammation, the said pathway also was
instrumental in causing increased α-SMA levels, a marker for stellate cell activation.
Interestingly, all these downstream events of liver injury associated with progressive
phases of NAFLD were inhibited using NOX2 inhibitors. Furthermore, our studies also
showed a distinct mechanism of PP2A-induced NOX2 activation. Use of AKT inhibitor in
Kupffer cells primed with leptin failed to either induce NOX2 activation or generation of
peroxynitrite, suggesting that PP2A might be activating NOX2 via AKT. The above results
may be a significant finding to advance our understanding of upstream modulation of
NOX2 via inhibition of PP2A. Furthermore, protein phosphatases may be negatively
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regulating the redox pathways in NAFLD, thus exerting a positive role in the prevention
of NAFLD progression to a more progressive phenotype.
In summary, the results assume tremendous significance in NASH pathogenesis
since PP2A inhibition both via endogenous and exogenous routes can be a cause of concern
in the overall scenario of NAFLD incidences around the globe. NAFLD progression to
NASH, though, is restricted only to a small percentage of patients with NAFLD; it is likely
that the “multiple hit paradigm” may be in play. Furthermore, our studies of PP2A
inhibition leading to increased fibrotic lesions in NAFLD thus also might be useful in
dealing with the exogenous threats from the environment as posed by increased incidences
of harmful algal blooms worldwide.
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Figure 2.1 Exogenous protein phosphatase 2A (PP2A) inhibition in mouse liver
exacerbates nonalcoholic fatty liver disease (NAFLD) pathology. Qualitative and
quantitative image analysis of microcystin (MC) effects on liver steatosis and fibrosis
induced in an NAFLD mouse model. A: representative histological images of liver
sections stained with hematoxylin-eosin (H&E), from lean mouse control and lean mouse
+ MC (n = 3), wild-type mouse NAFLD, and NAFLD + MC (n = 3). B: representative
histological images of the same groups of mice stained with picrosirius red (PicroS).
Images were taken at ×20 magnification. C: quantification of serum alanine
aminotransferase (ALT) level and comparison between control (lean and NAFLD) and
MC-tested groups. Automatic digital-imaging quantification of steatosis area (%) (D),
mean vesicle size (µm2) (E), fibrosis area (%) (F), and liver tissue density (%) (G) in lean
and NAFLD groups. H: Western blot analysis of β-actin and PP2A protein levels in the
liver homogenates of control (lean and NAFLD) and MC-tested groups. I: morphometric
band analysis of PP2A normalized against β-actin. The y-axis depicts the PP2A to β-actin
ratio. J: quantitative RT-PCR (qRT-PCR) analysis of mRNA expression of PP2AR
subunit in liver. K: qRT-PCR analysis of mRNA expression of PP2AC subunit in the
liver for control (lean and NAFLD) and MC-tested groups. L: Western blot analysis of βactin and PP2A protein levels in the human liver homogenates comparing control with
nonalcoholic steatohepatitis (NASH). M: morphometric band analysis of PP2A
normalized against β-actin. The y-axis depicts the PP2A-to-β-actin ratio. N: qRT-PCR
analysis of mRNA expression of PP2AR5D subunit in liver. O: qRT-PCR analysis of
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mRNA expression of PP2ACB subunit in liver comparing control with NASH. *P < 0.05.
Results were expressed as means ± SE.

Figure 2.2. Protein phosphatase 2A inhibition by microcystin (MC) activates Kupffer cells
and hepatic stellate cells and induces an inflammatory surge in mouse liver. Representative
histological images of liver sections immunostained with CD68 (A), α-smooth muscle actin
(SMA) (B), and CD11b (C) from lean mouse, lean mouse + MC, nonalcoholic fatty liver
disease (NAFLD), and NAFLD + MC (n = 3/group). Images were taken at ×20
magnification. Morphometric analysis of CD68 (D), α-SMA (E), and CD11b (F) in lean,
lean + MC, NAFLD, and NAFLD + MC groups (n = 3/group). Morphometric analysis was
expressed in percentage of positive immunoreactive area per regions of interest (ROIs) (3
ROIs/liver section). Quantitative RT-PCR analysis of mRNA expression of CCL2 (G),
TNF-α (H), and CD68 (I), in lean, lean + MC, NAFLD, and NAFLD + MC livers. The
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mRNA expressions were normalized with 18s and presented as fold change of lean group.
*P < 0.05. Results were expressed as means ± SE.
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Figure 2.3. The activation of Kupffer cells, hepatic stellate cells, and an inflammatory surge
in microcystin (MC)-exposed livers are mediated by NADPH oxidase 2-dependent
oxidative stress. A: representative images of P47 phox (red) and GP91phox (green)
immunofluorescence counterstained with DAPI (blue); colocalization indicated by arrows.
Images were taken at ×40 magnification. B: representative images of CD68 (red) and GP91
phox (green) immunofluorescence counterstained with DAPI (blue), from lean, lean + MC,
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nonalcoholic fatty liver disease (NAFLD), and NAFLD + MC (n = 3/group).
Colocalization was indicated by a circle. Images were taken at ×60 magnification. C:
morphometric analysis of P47 phox (red) and GP91 phox (green) colocalization expressed
in percentage of positive colocalized immunoreactive area per region of interest (ROI) (3
ROIs/liver section, n = 3 each group). D: quantitative RT-PCR (qRT-PCR) analysis of
mRNA expression of P47 phoxin lean and NAFLD groups treated with MC, expressed as
fold change of lean control group. Representative immunohistochemistry images depicting
3-nitrotyrosine (3NT) (E), CD68 (F), α-smooth muscle actin (SMA) (G), and CD11b (H)
expression in NAFLD, NAFLD + MC, and P47 phox knockout (KO) groups treated with
MC. All immunohistochemistry images were taken at ×20. Morphometric analysis of 3NT
(I), CD68 (J), α-SMA (K), and CD11b (L) immunoreactivity in NAFLD, NAFLD + MC,
and P47 KO mice treated with MC, expressed in percentage of positive immunoreactive
area per ROIs (n = 3/group, 3 ROIs/liver section). qRT-PCR analysis of mRNA expression
of CD68, CCL2 and TNF-α in NAFLD and P47 KO mice treated with MC, expressed as
fold change of NAFLD control group (M). *P < 0.05. Results were expressed as
means ± SE.

Figure 2.4. The protein phosphatase 2A inhibition activates NADPH oxidase 2-dependent
oxidative stress in Kupffer cells. Leptin was used to mimic a nonalcoholic fatty liver
disease (NAFLD) condition. Kupffer cells were exposed to 100 ng/mL leptin for 24 h. A:
representative immunofluorescence images depicting P47 phox (red) and GP-91 phox
(green) immunolabelling, counterstained with DAPI (blue), in control, leptin, microcystin
(MC), leptin + MC, and leptin + MC + apocynin (Apo) rat Kupffer cells groups. Images
were taken at ×60 magnification. B: morphometric analysis of the number of cells
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expressing a colocalization for P47 phox and GP91 phox. The y-axis shows colocalization
events/100-cell unit (n = 3, analysis from 3 separate microscopic fields). *P < 0.05. Results
were expressed as means ± SE.

Figure 2.5. Protein phosphatase 2A inhibitor microcystin (MC) synergistically increases
NADPH oxidase 2 (NOX2)-dependent tyrosine nitration in Kupffer cells. NOX2dependent tyrosin nitration marker 3-nitrotyrosine (3NT) immunoreactivity in leptinactivated rat Kupffer cell line. A: representative immunofluorescence images depicting
3NT immunoreactivity in control, leptin, MC, leptin + MC, leptin + MC + apocynin (Apo),
leptin + MC + DMPO, and leptin + MC + phenyl boronic acid (FBA) Kupffer cells groups.
Images were taken at ×20 magnification. B: morphometric analysis of the number of
immunoreactive cells for 3NT in control and treated groups. The y-axis shows
immunoreactive events/100-cell unit (n = 3, analysis from 3 separate microscopic fields).
*P < 0.05. Results were expressed as means ± SE.
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Figure 2.6. Exogenous protein phosphatase 2A inhibitor-induced oxidative stress triggers
miR21-dependent NF-κB pathway activation in nonalcoholic steatohepatitis. Histological
features and morphometric analysis of CD68, α-smooth muscle actin (SMA), and CD11b
expression in nonalcoholic fatty liver disease (NAFLD) and miR21 knockout (KO) mice.
A: quantitative RT-PCR (qRT-PCR) analysis of miRNA expression of miR21 in NAFLD,
NAFLD + microcystin (MC), and P47 KO + MC groups, expressed as fold change of
NAFLD group. B: qRT-PCR analysis of mRNA expression of CD68, CCL2, and TNF-α,
in NAFLD, NAFLD + MC, and miR21 KO groups. mRNA expression is represented as
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fold change of NAFLD. Representative immunohistochemical images depicting CD68 (C),
α-SMA (D), and CD11b (E) immunoreactivity in NAFLD, NAFLD + MC, and miR21 KO
groups. Morphometric analysis of CD68 (F), α-SMA (G), and CD11b (H) immunolabelling
in the various treated groups. The y-axis shows the percentage of positive immunoreactive
area/region of interest (ROI) (n = 3, analysis from 3 separate microscopic fields). *P <
0.05. Results were expressed as means ± SE.

Figure 2.7. Exogenous protein phosphatase 2A inhibitor-induced miR21 upregulation
acted downstream by modulating the p-AKT-NF-κB signaling pathway. A and B:
representative immunohistochemical images depicting p-AKT and P65 immunoreactivity
in nonalcoholic fatty liver disease (NAFLD), NAFLD + microcystin (MC), and miR21
knockout (KO) + MC groups. C and D: morphometric analysis of p-AKT and P65
immunolabelling in various treated groups; y-axis shows the percentage of positive
immunoreactive area/region of interest (ROI) (n = 3, analysis from 3 separate microscopic
fields). E: quantitative RT-PCR analysis of mRNA expression of RelA, NF-κB-P105, and
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P-65 in NAFLD, NAFLD + MC, and miR21 KO groups, expressed as fold change of
NAFLD. F: Western blot analysis of β-actin, p-AKT, AKT, and P65 protein levels in the
liver homogenates in NAFLD, NAFLD + MC, and miR21 KO groups. G: morphometric
band analysis of p-AKT normalized against AKT. The y-axis depicts the p-AKT-to-AKT
ratio. H: morphometric band analysis of P65 normalized against β-actin. The y-axis depicts
the P65-to-β-actin ratio in the liver of NAFLD, NAFLD + MC, and miR21 KO groups,
expressed as fold change of NAFLD. *P < 0.05. Results were expressed as means ± SE.
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Figure 2.8. NADPH oxidase 2-miR21-NF-κB signaling pathway in microcystin (MC)exposed immortalized rat Kupffer cells. A: miR21 expression in control, leptin, MC, leptin
+ MC, leptin + MC + apocynin (Apo), leptin + MC + DMPO, leptin + MC + miR21
inhibitor (inh), and leptin + MC + phenyl boronic acid (FBA). miRNA expression is
represented as fold change of control group. B: representative immunofluorescence images
depicting CD68 (red), counterstained with DAPI (blue), in control and tested rat Kupffer
cell groups. Images were taken at ×20 magnification. C: immunofluorescence images
depicting CD68 (red), counterstained with DAPI (blue), in leptin + MC and MC groups of
rat Kupffer cells. Images were taken at ×40 magnification. D: morphometric analysis of
CD68 immunoreactivity; y-axis shows the percentage of activated Kupffer cells per region
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of interest (n = 3, analysis from 3 separate microscopic fields). *P < 0.05. Results were
expressed as means ± SE.

Figure 2.9. Exogenous protein phosphatase 2A inhibitor exposure increases M1 phenotype
in Kupffer cells. Immunoreactivity of β-tubulin and inducible nitric oxide synthase (iNOS)
and quantification of nitirc oxide in leptin-activated rat Kupffer cell line. A and B:
immunofluorescence images depicting β-tubulin and NOS2 (iNOS) (red), counterstained
with DAPI (blue), in control, leptin, microcystin (MC), leptin + MC, leptin + MC +
apocynin (Apo), leptin + MC + DMPO, leptin + MC + miR21 inhibitor (inh) and leptin +
MC + phenyl boronic acid (FBA) groups of rat Kupffer cells. Images were taken at ×60
magnification. C: nitric oxide release measured as total nitrite (μM) in variously treated
leptin-activated Kupffer cells. *P < 0.05. Results were expressed as means ± SE.
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Figure 2.10. Exogenous protein phosphatase 2A inhibitor exposure activates hepatic
stellate cells via NADPH oxidase 2-miR21 axis. A: immunofluorescence images depicting
α-smooth muscle actin (SMA) (green), counterstained with DAPI (blue), in control, leptin,
microcystin (MC), leptin + MC, leptin + MC + apocynin (Apo), leptin + MC + DMPO,
leptin + MC + miR21 inhibitor (inh), and leptin + MC + phenyl boronic acid (FBA) groups
of 8B rat hepatic stellate cells. Images were taken at ×40 magnification. B: morphometric
analysis of α-SMA immunoreactivity; y-axis shows the percentage of α-SMA-positive
cells per region of interest (ROI) (n = 3, analysis from 3 separate microscopic fields). *P <
0.05. Results were expressed as means ± SE.
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Figure 2.11. Exogenous protein phosphatase 2A (PP2A) inhibitor activates NADPH
oxidase 2 via AKT pathway. Immunoreactivity and morphometric analysis of P47 phox
and GP91 phox expression in leptin and microcystin (MC) -treated rat Kupffer cells. A:
immunofluorescence images depicting P47 phox (red) and GP91 phox (green)
colocalization, counterstained with DAPI (blue), in control, MC, PP2A inhibitor (inh),
AKT inh + MC, and AKT inh + PP2A inh. B: immunofluorescence images depicting P47
phox (red) and GP91 phox (green) colocalization, counterstained with DAPI (blue), in
control, leptin, leptin + MC, Leptin + PP2A inh, leptin + MC + AKT inh, and leptin +
PP2A inh + AKT inh. C and D: quantitative analysis of the number of colocalized cells
for P47 phox and GP91 phox in the various Kupffer cell line groups; y-axis shows
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colocalization events/100-cell unit (n = 3, analysis from 3 separate microscopic fields).
*P < 0.05. Results were expressed as means ± SE.

Figure 2.12. Exogenous protein phosphatase 2A (PP2A) inhibitor-activated NADPH
oxidase 2 generates oxidative stress via AKT pathway. Immunoreactivity and
morphometric analysis of 3-nitrotyrosine (3NT) expression in rat Kupffer cells. A:
immunofluorescence images depicting 3NT immunoreactivity (red), counterstained with
DAPI (blue), in control, microcystin (MC), PP2A inhibitor (inh), MC + AKT inh, and
PP2A inh + AKTinh. B: immunofluorescence images depicting P47 phox (red) and GP91
phox (green) colocalization, counterstained with DAPI (blue), in control, leptin, leptin +
MC, leptin + PP2A inh, leptin + MC + AKT inh, and leptin + PP2A inh + AKT inh. C and
D: quantitative analysis of the number of immunoreactive cells for 3NT immunoreactivity
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in various treated groups; y-axis shows colocalization events/100-cell unit (n = 3, analysis
from 3 separate microscopic fields). *P < 0.05. Results were expressed as means ± SE.

Figure 2.13. Mechanism of protein phosphatase 2A (PP2A) inhibition-induced
nonalcoholic fatty liver disease (NAFLD) pathology. Graphical representation showing
upregulation of miR21 via NADPH oxidase 2 (NOX2) activation by exogenous PP2A
inhibitor (microcystin) in Kupffer cells, leading to transcriptional upregulation of
inflammatory cytokines, M1 polarization, and fibrosis in NAFLD liver. α-SMA, α-smooth
muscle actin; Apo, apocynin; FBA, phenyl boronic acid.

.
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CHAPTER 3
EXOGENOUS PP2A INHIBITOR IN NAFLD CAN LEAD TO
PYROPTOSIS AS WELL AS HEDGEHOG SIGNALING PATHWAY
ACTIVATION VIA NOX2-DEPENDENT ACTIVATION OF MIR212

2
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NAFLD can lead to pyroptosis as well as hedgehog signaling pathway activation via Nox2-dependent
activation of Mir21. To be submitted.
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Abstract:
Chronic Microcystin-LR exposure can cause serious liver injury. Liver injury can
have multiple outcomes that can be studied in molecular pathology. One of them is a
pyroptosis, which is a type of different types of cell death mechanisms. It is a result of
releasing caspase 1 and its activation. Gasdermine D is a prevalent marker for pyroptosis.
The second outcome is HH-signaling network's deregulation that may contribute to the
pathogenesis and sequelae of liver damage resulting from metabolic syndrome. We in the
previous study showed that MC-LR toxicity was be involved in the PP2A signaling
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pathway and various cellular activities. The purpose of the present study was to investigate
the impact of microcystin on hepatic pyroptosis as well as on hepatic fibrosis in vitro.
Combined immunofluorescence imaging of transmembrane proteins E-Cadherin and
GSDMD showed significant enhanced colocalization events in cells that is primed with
leptin and exposed to MC as compared with the other groups especially the
pharmacologically inhibited one. In addition, inhibitors which are added to leptin primed
MC exposed stellate cell showed significant deceased in Gli1, PTCH1, IHH, SHH gene
expression. Thus, increased pyroptosis as well as activate profibrotic hedgehog signaling
pathway and activated stellate cells happened via NOX2 mediated ROS.
3.1 INTRODUCTION
Microcystin is known as a potent liver toxin that is available in pond waters that
have the blue-green alga such as Microcystis aeruginosa [44]. The major determining factor
of microcystin hepatotoxicity has the ability to accumulate in liver cells through
mechanisms that facilitate its uptake [51]. OATP transporter family have been proven in
research that they are responsible for the liver uptake as it shows that Oatp1b2-null mice
has absence of the liver toxicity after being exposed to microcystin [46, 86]. The main
mechanism of microcystin toxicity is by Protein phosphatase 2A (PP2A) inhibition [51].
We have shown that Microcystin is exacerbating NASH in NAFLD condition [87].
Nonalcoholic steatohepatitis (NASH) is a hepatic form of metabolic syndrome that
is a result of the most widely known model of "two-hits" or "multiple-hits" hypothesis [12,
88]. It is started with long term liver fat accumulation, which is resulting in the primary hit.
The main impact of asymptomatic primary hit is that it makes the liver more susceptible to
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secondary hits that came as a result of exposure to an environmental toxin that causes
additional stress, such as oxidative stress, as well as subsequent lipid peroxidation [6, 11,
89]. This will be followed by release of proinflammatory cytokines, and adipokines that
cause the inflammation as well as fibrosis. Cellular death is associated with NASH
conditions as a result of release of proinflammatory cytokines as well as the oxidative stress
[90].
Eukaryotic cells are vulnerable to cell death in NASH condition where the loss of
demarcation of cell margins and organelles can be seen microscopically happening in the
intact tissue [90]. In eukaryotic cells, a wide range of cell death mechanisms has been
shown by many researchers using molecular pathology markers. There are many
mechanisms for cellular deaths such as apoptosis , necrosis, and pyroptosis [91]. One of
these mechanisms is pyroptosis, which is a distinctive type of programmed cell death that
is dependent on Caspase 1 activation, and it is characterized by release of pro-inflammatory
cytokines such as of IL-1β and IL-18 , as well as cellular swell, burst and death [92].
There is a usual association between NASH pathophysiology and fibrosis
particularly on its late stage as is shown by different research in molecular pathology of
NAFLD [93-95]. Hepatic fibrosis is strongly associated with the aggregation of
extracellular matrix (ECM) proteins in the liver parenchyma, primarily type I collagen,
which is a characteristic in many chronic liver pathologies. This happens in liver as a
response to wound-healing in chronic liver injury. The primary collagen-producing cells
in the liver parenchyma were recognized as hepatic stellate cells (HSCs) [96]. We have
already shown that Microcystin is causing activation of hepatic stellate cells (HSCs) [87].
This step is a crucial cellular event in a hepatic fibrosis [97]. It has been known that
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Hedgehog signaling pathway can contribute considerably to liver fibrosis as well as in the
process of activation of HSC [98].
The purpose of the present study was to investigate the impact of Microcystin as
PP2 inhibitor to induce pyrptosis as well as on hepatic fibrosis in vitro assessment.

3.2 MATERIALS AND METHODS

Materials:
Specific chemicals such as Microcystin-LR was purchased from Cayman (Ann
Arbor, MI), and Leptin was purchased from BioVision (Milpitas, CA). Anti-E Cadherin
primary antibody was purchased from Abcam (Cambridge, MA). Anti-Gasdermin D also
was purchased from Santacruz Biotechnology (Dallas, TX). Fluorescence conjugated
(Alexa fluor) secondary antibodies that used based on primary antibodies as well as
ProLong Gold antifade mounting media with DAPI were bought from Thermo Fisher
Scientific (Waltham, MA). miR21 inhibitor was bought from Qiagen (Valencia, CA).
Phenyl Boronic Acid (FBA) and the spin trap 5,5 dimethyl-1- pyrroline N-oxide DMPO
were bought from Alexis biochemical (San Diego, CA) All other chemicals not specified
above were analytical grade and bought from Sigma Chemical Company.
Kupffer Cell Culture and Treatments
Immortalized rat Kupffer cell line (SV40) has been grown and cultured as described
in the chapter 2. The cells were either kept without treatment (control) or treated with either
leptin (100ng/ml), MC-LR (20μM), or leptin followed with MC-LR at the same doses.
Certain cell groups have been incubated with pharmacological inhibitor first such as
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Apocynin (100 μM) , Phenyl Boronic Acid (FBA) (100 μM) , (100 mM) the spin trap 5,5
dimethyl-1- pyrroline N-oxide DMPO , or (20 µM) miR21 inhibitor. Then, followed by
incubation with leptin, and microcystin at the same doses. All cells groups immediately
after 24 hours incubation period were then plated on coverslips MatTek Corp, (Ashland,
MA) for immunofluorescence staining according to our lab protocol that specified in
chapter 2. Cells were incubated specifically with primary antibodies anti- Gasdermin D,
and anti- E Cadherin, Then, cells groups followed by species-specific Alexa Fluor 633 and
488 in order to show the colocalization events. The stained cells attached on the coverslips
were mounted on slides with ProLong Gold antifade reagent with DAPI (Life
Technologies) and viewed under 60X oil magnification with an Olympus BX51
microscope.
Stellate Cells Culture and Treatments:
Immortalized rat hepatic stellate cell line (8B) kindly provided to us by Dr. Anna
Mae Diehl (Duke-Gastroenterology), were cultured as described in the chapter 2. The cells
were then treated the same way regarding to groups and treatment as Kupffer cells. Then
immediately after treatments has completed, the cells were lysed in Trizol for mRNA
extraction. mRNA levels of gene expression of Immortalized rat hepatic stellate cell line
(8B) were measured using our standard laboratory protocol by using quantitative real-time
reverse transcription-polymerase chain reaction (qRT-PCR). The primers used for Realtime PCR in 5’ to 3’ orientations are table 3.1.
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Table 3.1. Primer sequences for the different target genes.
Gene

Primer sequence

Gli 1

Sense: AACTCCACGAGCACACAGG

(Rat)

Antisense: GCTCAGGTTTCTCCTCTCTC

Shh

Sense: CTGGCCAGATGTTTTCTGGT

(Rat)

Antisense: TAAAGGGGTCAGCTTTTTGG

IHH

Sense: CCCTCGTCTTGGTGTAGAG

(Rat)

Antisense: GAATCGCAGTCAGAGCTAGC

PTCH 1

Sense: CCTCTTGATGTGGCCCTTGT

(Rat)

Antisense: GGCAGCCCTATCCTCATTCC

Statistical Analyses:
All cellular studies in vitro have been repeated at least three times (n = 3). The
statistical analysis was carried out by unpaired t-test and ANOVA. For all analyses, P <
0.05 was considered statistically significant.

3.3 RESULTS

Microcystin induces Pyroptosis via NOX2-miR21 dependent pathway
Pyroptosis is a novel caspage-1 dependent lytic cell death process mediated by
formation of inflammasome complex [99]. Previous studies suggest that NOX dependent
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ROS and NF-kB activation modulate inflammasome formation and subsequent pyroptosis
[100]. Recently, pyroptosis defined as gasdermin D (GSDMD)-mediated programmed
necrosis since GSDMD represent a substrate for both caspage-1 and caspage-11/4/5 which
are mediators of pyroptosis [101]. Next, we investigated whether MC induced NOX2miR21-Nf-kB pathway activate GSDMD mediated pyroptosis in NASH. Dual
immunofluorescence imaging of transmembrane protein E-Cadherin and GSDMD showed
significant increased colocalization events in leptin primed cells exposed with MC as
compared with vehicle control, leptin or MC treated cells (Fig.3.1, A,B). Interestingly,
leptin primed cell co-treated with MC and Apo, DMPO, FBA and miR21 inhibitor showed
significant decreased in E-Cadherin-GSDMD colocalization event (Fig.3.1,A,B). Results
suggest that the increased localization of GSDMD to the membrane causes membrane
permeability and GSDMD mediated cell death, thus increased pyroptosis.
Microcystin induced NOX2 and ROS activate profibrogenic hedgehog signaling in
hepatic stellate cells
Next, we investigated whether MC induced NOX2-miR21 axis or NOX2
mediators activate stellate cells, pro-fibrogenic hedgehog signaling pathway and
subsequent fibrosis. Leptin primed hepatic stellate cell were exposed with MC and coexposed with Apo, DMPO, FBA and miR21 inhibitor to test the role of NOX2 mediators
or miR21 in liver fibrosis. Results suggest that activation of stellate cells is mediated by
MC induced NOX2 and oxidative stress instead NOX2-miR21 axis. Further, to correlate
MC induced activation of profibrotic hedgehog signaling pathway, the mRNA
expression of Gli1 gene (a hedgehog transcription factor), Patched 1 (PTCH1), Indian
hedgehog (IHH) and Sonic hedgehog (SHH) were analyzed. The leptin primed stellate
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cells exposed with MC showed significant increase in Gli1, PTCH1, IHH, SHH gene
expression as compared to control, leptin or MC alone groups (Fig. 11B-E). However,
Apo, DMPO, FBA or miR21 treatment to leptin primed MC exposed stellate cell showed
significant deceased in Gli1, PTCH1, IHH, SHH gene expression (Fig.3.2,B-E). Results
suggest that NOX2 mediated ROS activate profibrotic hedgehog signaling pathway and
activate stellate cells.
3.4 DISCUSSION
The present study builds on our findings which we have reported in chapter 2. We
investigated the mechanisms by which chronic exposure to MC-LR causes liver injury
through activation of NOX-2 , profibrogenic hedgehog signaling and pyroptosis in hepatic
stellate cells and Kupffer cells, in NAFLD.
We found that there was enhanced concentrations of Gli1, patched (PTCH1) and
sonic hedgehog ligand SHH, which are significant mediators of the hedgehog signaling
pathway which other research group had earlier shown to play a prominent part in liver
fibrogenesis [102-104]. Interestingly, all these increases in the genes of the hedgehog
signaling pathway following microcystin exposure that are associated with progressive
phases of NAFLD were decreased when NOX2 inhibitors ,miR21 inhibitor, or FBA , were
applied. However, we have seen in hepatic stellate cell (HSC) culture that MC enhanced
the activation as well as profibrogenic proliferation of HSCs, which may have been through
enhanced hedgehog signaling pathway via NOX2 dependent pathway.
One of the main regulators among others which are responsible for the growth of
humans is the Hedgehog signaling pathway. Essentially, it regulates the progress of furrow
by induction of at least two signals. The downstream of the hedgehog signaling can behave
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as a long-range signaling molecule on anterior unvarying cells and prompts the expression
of Hairy [105]. The pathway is being studied by the field of molecular biology, as it is of
equal importance throughout the development of embryos. Namely, the Hedgehog
signaling is a pathway which passes to the cells of the embryo the necessary information
for proper cell differentiation. Different parts of the embryo concentrate different amounts
of Hedgehog signaling proteins. Moreover, it is discovered that the malfunctioning of
Hedgehog signaling is correlated with diseases such as basal cell carcinoma [106].
Furthermore, in recent researches, it is found that Hedgehog signaling plays also a hallmark
role in regulating as well as controlling adult stem cells which have the potential for
maintaining and regenerating human tissues [107]. In addition, numerous pharmaceutical
companies have begun developing drugs which specifically aim in targeting the Hedgehog
signaling pathway, as it is found involved in the development of certain types of cancer
[108]. In NAFLD, the activity of the hepatic Hedgehog signaling pathway is connected to
the extent of the severity of hepatic injury and with the levels of metabolic syndrome
clinical parameters, which are expected to be predictive of advanced liver disease. Thus,
the upregulation of the hedgehog signaling pathway can perhaps add to the pathogenesis
and liver injury sequelae. On top of that, the increased activity of the pathway is directly
connected with histological features of liver injury such as portal inflammation, hepatocyte
ballooning and fibrosis. That supports further the association between Hedgehog signaling
and the damage of the liver [109]. As is known in NASH, Hedgehog-stimulated hepatic
stellate cells gain a pro-fibrogenic phenotype, as they transdifferentiated from epithelialto-mesenchymal until becoming myofibroblasts. Moreover, after they transform into
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myofibroblasts, they gain the ability to release pro-inflammatory and chemotactic
cytokines [102-104].
Using a cell culture model of NAFLD that was induced by leptin, we show that MC
treatment could assemble Gasdermin D (GSDMD) with transmembrane protein ECadherin.

Leptin treatment primed cells that were co-treated with MC and

pharmacological inhibitors such as Apo, DMPO, FBA and miR21 showed a substantial
decline in this assembly events. Since caspase 1 can also cleave Gasdermine D because of
pyroptosis, this results in the translocation of the membrane where they polymerize and
form membrane pores where it can be assembled with E-Cadherin [110]. Another result is
the release of pro-inflammatory cytokines through these membrane pores. This can be
showed as a distinct mechanism of PP2A-induced NOX-2 activation.
In summary, we conclude that exposure to exogenous PP2A inhibitor such as
microcystin can result in increased pyroptosis in Kupffer cells and activation of
profibrogenic hedgehog signaling in hepatic stellate cells. We also conclude that these
events are both linked to activation of NOX2-miRNA21 dependent pathway.
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Figure 3.1. Exogenous PP2A inhibitorexposure induces pyroptosisin Kupffer
cells.Immunoreactivity and morphometric analysis of Gasdermin D and E-cadherin
expression in leptin-activated rat Kupffer cells. (A)Immunofluorescence images depicting
Gasdermin D (GSDMD) (green) and Cadherin (red), colocalization (yellow),
counterstained
with
DAPI
(blue)
in
control,
leptin,
MC,leptin+MC,
leptin+MC+apocynin,leptin+MC+DMPO, leptin+MC+miR21 inh. and leptin+MC+FBA
groups of rat Kupffer cells. Images were taken at 60X magnification. (B) Quantification of
the number of colocalized cells for Gasdermin D (GSDMD) and E-Cadherin
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immunoreactivity, Y-axis shows colocalization events/100-cell unit (n=3, analysis from
three separate microscopic fields). *p < 0.05. Results were expressed as mean ± SEM.

Figure 3.2.Exogenous PP2A inhibitorexposure activates profibrogenic hedgehog
signaling in hepatic stellate cells via NOX2-miR21 axis. qRT-PCR analysis of mRNA
expression of Gli1, PTCH1, IHH and SHH in leptin-activated rat hepatic stellate cells
line. (A-D) qRT-PCR analysis of mRNA expression of Gli1, IHH, PTCH1, and SHHin
various treated groups. *p < 0.05. Results were expressed as mean ± SEM.
.

64

CHAPTER 4
EARLY CHILDHOOD EXPOSURE AND PRIMING TO ALGAL
TOXINS INDUCE MURINE ADULT HEPATIC INJURY FOLLOWING
HIGH FAT DIET FEEDING VIA NLRP3 INFLAMMASOMES 3

3
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Raychoudhury S, Nagarkatti M, Nagarkatti P, Chatterjee S. Early childhood exposure and priming to algal
toxins induce murine adult hepatic injury following high fat diet feeding via NLRP3 inflammasomes. To be
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Abstract:
Evidence is strong for early childhood exposure effects individuals with physical ,
biological , chemical , or psychological stimuli. Results from American Academy of
Pediatrics show that infants and children are at risk for early exposure to microcystin.
Notably, infants and children are known to consume more water relative to their body
weight when compared to adults and thus are at increased risk of water borne exposures to
environmental contaminants. The present report tests the hypothesis that early childhood
exposure to microcystin (MC), a PP2A inhibitor and a principal component of harmful
algal blooms activate Kupffer cells and hepatic stellate cells, which are considered to be
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crucial mediators in hepatic fibrogenesis in an underlying condition of NAFLD. Mice
exposed to subchronic doses of microcystin-LR (MC-LR) for two weeks immediately after
the end of weaning and with a parallel high fat diet co-exposure showed classical symptoms
of early NAFLD linked inflammation. Cytokines and chemokines such as CD68, IL1β,
MCP-1, and TNF-α, as well as α-SMA, hallmarks of NAFLD-linked inflammation were
increased in the groups that were exposed to microcystin with high fat diet compared to
the vehicle group. Also, NLRP3 KO mice showed significant decrease in the inflammation
suggesting a decisive role of NLRP3 linked inflammasome activation and increased
inflammation in these mice. The same trends were observed for liver injury biomarker IL1β, indicating a worsening outcome in liver health. Clinically, serum alanine
aminotransferase (ALT) levels were significantly higher in the group that was primed to
Microcystin followed by high fat feeding when compared to controls. The results suggest
that toddlers and children might be at a greater risk of microcystin exposure and subsequent
liver damage since data generated in mice models are highly translatable to humans. The
results also bode well to strong clinical data that suggest increased incidences of NAFLD
and NASH cases in children and juveniles in the US and around the developed world.
4.1 INTRODUCTION
Algae as well as cyanobacteria are detected in all types of aquatic environments. It
has been published on a large number of studies that the presence of microcystins in surface
waters that found worldwide [111]. Microcystins poses a strong risk to human health
through drinking water. Drinking water has been reported to be contaminated by
microcystin in many regions of harmful algal bloom [112-115]. For instance, there was an
event of contamination of drinking water with Microcystis toxins in Caruarù, Brazil. This
67

was the first serious outbreak that was reported to cause symptoms of hepatotoxicity in
humans as similar to what has been seen in laboratory studies. These data that came from
dialysis center gave proof that microcystins are also potent inhibitors of Protein
phosphatase 2A (PP2A) enzymes in humans [116, 117].
Early childhood exposure has the potential to have long-life effects on individuals
exposed to physical, biological, chemical, or psychological stimuli. According to the
American Academy of Pediatrics, infants and children are at elevated risk for early
exposure to microcystin, a constituent of harmful algal blooms. Infants and children have
been known to consume more water relative to their body weight when compared to adults
and thus can incur higher risks to exposure from water-borne toxins such as microcystin.
For example, the mean intake for water in infants and children are around 43 and 35
ml/kg/day, respectively. These values decrease when children are in their teen and adult
ages, where they have the mean water intake of 18 and 19 ml/kg/day, respectively [118].
Also, children may be at the risk from exposure to coastal blooms from recreating near
ponds and beach shores.
Several studies have also established that the tissues and organs of the body undergo
fast development during fetal life as well as early infancy, during which any sort of toxic
insult can have significant impacts [119, 120]. From progenitor cells stage, in fetus liver
grows into a well-differentiated organ in which bile secretion can be started through 12
weeks gestation. It requires up to two years to reach full maturity after birth, in order to
perform complete liver function [121].
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We have reported in our studies that the activation of NLRP3-inflammasome in
dysbiosis associated with NAFLD conditions following microcystin exposure [122].
NLRP3 inflammasome is a multiprotein complex that resides inside the cell structure [123].
It has different parts like the cytoplasmic receptor NLRP3 or also known as inflammasome
sensor molecule, the adaptor protein caspase-recruitment domain ASC and the effector
protein pro-caspase 1. Upon activation, their parts are assembled together yielding several
pro-caspase sub-units close to each other. This pro-caspase 1 when close together within
cytosolic multimolecular complexes, they cleave themselves in order to release the mature
or active form, caspase 1. The activated caspase-1 further cleaves the , pro-IL-1β as well
as proIL-18 into their mature interleukin forms IL-1β and IL-18 to be released into the
system [92, 124-126].
In the present study, we used a juvenile mice model primed them with microcystin
and fed them on high fat diet in order to investigate the role of early microcystin exposure
in DIO model. We have chosen to investigate mechanistically whether early microcystin
exposure triggered the NLRP3 inflammasome activation and intensified livery injury
outcomes.

2.2 MATERIALS AND METHODS

Materials
All other chemicals needed for this study were of analytical grade and were
purchased from Sigma Chemical Company unless indicated otherwise. From Cayman
(Ann Arbor, MI), Microcystin-LR was purchased (Ann Arbor, MI). From The Jackson
Laboratories (Bar Harbor, ME) ,wild-type and gene-specific knockout (KO) mice
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including NLRP3 knock out mice were purchased. From Research Diets (New Brunswick,
NJ), the animal diet specifically high-fat (60% KCal) (HFD) diet were purchased. From
Abcam (Cambridge, MA), primary antibodies such as anti-CD68, anti-α-SMA, anti-3
nitrotyrosine (3NT), anti-IL-1β, anti- GP91 phox, anti-P47phox, and anti-αSMA were
purchased. Anti-NLRP3 and anti-ASC2 were purchased from Santacruz Biotechnology
(Dallas, TX). From Abclonal (Woburn, MA), anti-IL18 antibody was purchased. From
Vector Laboratories (Vectastain Elite ABC kit, Burlingame, CA), we purchased Speciesspecific biotinylated conjugated secondary antibody and streptavidin-horseradish
peroxidase. From Thermo Fisher Scientific (Waltham, MA), fluorescence conjugated
(Alexa fluor) secondary antibodies as well as ProLong Gold antifade mounting media with
DAPI were bought. From IHC world (Woodstock, MD), NovaUltra Special Stain Kits were
purchased. At AML laboratories (Baltimore, MD), paraffin embedding of the liver tissue
sections on slides were performed.
Mouse model
Experimental Models Used:
Pathogen-free, Juvenile, male mice with C57BL/6J background (Jackson
Laboratories, Bar Harbor, ME) will be used in the study. At the age of 4 weeks, they have
been administered with vehicle (ethanol then dissolved in PBS), or microcystin-LR (MCLR) (10µ/kg, 5 dosages per week), through the intraperitoneal route for two weeks before
starting in diet regime or euthanized . A group of injected mice were fed with a high-fat
(60% KCal) (HFD) diet, (Research diets, New Brunswich, NJ) for 4 weeks and used as a
model of diet-induced obesity (DIO+MC model) until the feeding is over and they are
euthanized. Also, another group of mice were fed with a Chow diet (Lean MC model).
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Also, mice with vehicle were fed the regular chow diet (Lean Control model). Another set
of mice have not been injected with MC-RL were fed the HFD and used as (DIO model)
in this study. An additional set of NLRP3 KO mice at the age of 4 weeks, they have been
administered with microcystin-LR (MC-LR) at same dose. Then they had fed with HFD
until the feeding is over and they were euthanized. All mice will be housed with 3-5
mice/cage at 23–24°C on a 12:12-h light-dark cycle with libitum access to food and water.
The complete amount of mice in each group was evaluated on the basis of calculations that
provided sufficient statistical power of 0.5. All animals have been treated in strict
accordance with the NIH Guide for the Humane Care and Use of Laboratory Animals, and
the experiments will be approved by the institutional review board at the University of
South Carolina at Columbia. Mice had been euthanized at the completion of the diet regime
or after priming and serum and liver tissue collected for further processing. Liver tissue
sections from each mouse after euthanized were collected and fixed in 10% neutral
buffered formalin.
Histopathology:
Sections of liver tissue from each mouse after were collected and fixed in 10%
neutral buffered formalin. These Formalin-Fixed Paraffin-Embedded (FFPE) liver tissues
were cut into 5-m thick sections. For histological examinations, liver sections slides were
deparaffinized using standard protocol and stained with hematoxylin and eosin (H&E) and
Picro-Sirius red using NovaUltra Special Stain Kits following manufacturer’s protocol
(IHC world, Woodstock, MD) and then observed under the light microscope using 20x
objectives.
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Serum ALT Measurements:
Serum alanine aminotransferase (ALT) levels were quantified and measured using
an automated analyzer at the University of Georgia Clinical pathology core facility.
Immunohistochemistry:
Using standard protocol , formalin-fixed, paraffin-embedded liver tissue sections
(5-μm thick) from all the mice groups were deparaffinized and subjected to antigen
retrieval. The primary antibodies CD68, 3-nitrotyrosine , and TGF-β

are used at

recommended dilutions. The rest of the experiment was explained in details in chapter 2.
Sections were finally observed under a 20X objective using an Olympus BX51 microscope
(Olympus, America).
Immunofluorescence Microscopy:
Using standard protocol , formalin-fixed, paraffin-embedded liver tissue sections
(5-μm thick) from all the mice groups were deparaffinized and subjected to antigen
retrieval. The primary antibodies α-SMA, NLRP3,ASC2, IL-1β, IL-18 are used at
recommended dilutions. Species-specific anti-IgG secondary antibodies conjugated with
Alexa Fluor 488 and Alexa Fluor 633 (Invitrogen, California, USA) ,were used against the
appropriate primary antibodies. The rest of the experiment was explained in details in
chapter 2. Sections were finally observed under a 40X objective using an Olympus BX51
microscope (Olympus, America).
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Quantitative Real-Time Polymerase Chain Reaction:
Gene expression for mRNA levels from juvenile mice liver tissue were measured
by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) by
following our routine laboratory protocol. The primers used for RT-PCR in 5′ to 3′
orientations are provided in Table 4.1.
Table 4.1. Primer sequences for the different target genes.
Gene

Primer sequence

CD68

Forward: GCTACATGGCGGTGGAGTACAA

(Mouse)

Reverse: ATGATGAGAGGCAGCAAGATGG

MCP-1

Forward: CACAGTTGCCGGCTGGAGCAT

(Mouse)

Reverse: GTAGCAGCAGGTGAGTGGGGC

TNF-α

Sense: CAACGCCCTCCTGGCCAACG

(Mouse)

Antisense: TCGGGGCAGCCTTGTCCCTT

IL-1β

Sense: CCTCGGCCAAGACAGGTCGC

(Mouse)

Antisense: TGCCCATCAGAGGCAAGGAGGA

TGF-β

Sense: CTCACCGCGACTCCTGCTGC

(Mouse)

Antisense: TCGGAGAGCGGGAACCCTCG

α-SMA

Sense: GGAGAAGCCCAGCCAGTCGC

(Mouse)

Antisense: ACCATTGTCGCACACCAGGGC

NLRP3

Sense: GGTGACCTTGTGTGTGCTTG

(Mouse)

Antisense: ATGTCCTGAGCCATGGAAGC

ASC-2

Sense: GGACAGTACCAGGCAGTTCG
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(Mouse)

Antisense: TTCTTGCAGGTCAGGTTCCA

IL-18

Sense: ACACCACAAAACCTCAGCCA

(Mouse)

Antisense: AGGGACTTGAAACCAGAGCC

Statistical Analyses:
All mice experiments were repeated three times with at least 3 mice per group (n =
3; data from each group of 3 mice were pooled). Data were represented as mean ± S.E. The
graphs were plotted using GraphPad Software, Inc.The statistical analysis was carried out
by unpaired t-test and ANOVA. For all analyses, P < 0.05 was considered statistically
significant.

4.3 RESULTS

Early priming with microcystin will induces liver injury
To determine the effects of early priming exposure of MC-LR in mice immediately
after weaning on liver parenchyma , liver histopathology as well as inflammatory markers
were analyzed. The early primed MC-LR mice showed an increase in liver injury
pathophysiology, as shown by increased infiltrating immune cells (early inflammation)
when compared with lean mice that only exposed to vehicles (Fig. 4.1 A). Moreover, in
order to investigate if early priming with MC-LR can induce activation for both Kupffer
cells and hepatic stellate cells, immunoreactivities of Kupffer cell activation marker CD68,
as well as hepatic stellate cell activation marker α-SMA, were analyzed in liver tissue
slices. Results showed that there was a significant increase in CD68 immunoreactivity in
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early primed mice with MC-LR as compared with Lean group of mice that primed with
vehicle (P < 0.001) (Fig. 4.1, C, and F). These findings have been further confirmed at the
mRNA levels of CD68 as well as the inflammatory markers. CD68 mRNA expression in
mice that primed with MC has increased significantly when compared with Lean mice (P
= 0.008) (Fig. 3.1, H). Moreover, in order to test that the activation of Kupffer cells took
part in a proinflammatory phenotype, mRNA expression of proinflammatory cytokines
such as monocyte-chemoattractant protein-1 (MCP-1), Interleukin 1 beta (IL-1β), and
tumor necrosis factor-α (TNF-α) were evaluated. The result showed that there was a
significant increase in CCL2, IL-1β and TNF-α mRNA expression in mice that primed with
MC as compared with lean mice (P < 0.001, P=0.005, and P < 0.001 , respectively) (Fig.
3.1, H). α-SMA immunoreactivity, a characteristic of stellate cell activation, then was
significantly increased as well in early primed mice with MC-LR groups when compared
with Lean mice group (P < 0.001) (Fig. 3.1, D and G). α-SMA mRNA expressions in mice
that primed with MC-LR have increased significantly when compared with lean mice (P
< 0.001) (Fig. 3.1, H). Furthermore, liver tissues also were analyzed next for fibrosis status
by assessing picrosirius red staining. The early primed MC mice liver showed significantly
increased picrosirius red staining reactivity as compared with Lean mice (P < 0.001) (Fig.
3.1, B and E). The above results thus suggested that an early MC exposure will induce
early inflammation during the process of increased proinflammatory responses via MCP1,
IL-1β and TNF-α.
Early exposure to microcystin followed by HFD will exacerbate liver injury
We, as will other authors, have shown that toxins from the environmental exposure
are acting as a second hit to intensify the progression of NAFLD from stage to advanced
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one [6, 8]. We have also published that exogenous inhibitors of PP2A such as microcystin
can worsen the pathophysiology of NAFLD [87]. To investigate the role of early exposure
to MC-LR in induction of liver injury in DIO model, we used a low, chronic dose of MCLR in mice immediately after weaning to induce liver injury, followed by feeding them
HFD (DIO + MC). Results showed that DIO+MC group that shows the typical features of
liver injury include increased infiltrating immune cells (inflammation), and hepatocytes
ballooning when compared to with DIO control mice alone, lean mice exposed to MC, or
lean mice (Fig. 4.2, A). Early exposure to microcystin also significantly elevated Serum
ALT level in DIO+MC mice as compared to lean, lean mice exposed to MC and DIO only
mice (P<0.05) (Fig. 4.2, M) . Moreover, analysis of picrosirius staining in the early
exposure to microcystin followed by HFD (DIO+MC) mice group showed increased
reactivity as compared to lean, lean mice exposed to MC and DIO only mice (P<0.05) (Fig.
4.2, B and F). CD68 immunoreactivity as well as mRNA levels is significantly increased
in early exposure to microcystin followed by HFD mice group as compared to lean, lean
mice exposed to MC and DIO only mice (P<0.05) (Fig. 4.2, C,G and J). This is indicative
of Kupffer cell activation in early exposure to microcystin followed by HFD mice group
as evidenced by significant increase in CD68. Mice early exposed to MC also showed
increase mRNA expression of proinflammatory cytokines TNF-α, IL-1β, and MCP1 as
compared to the other groups (P<0.05) (Fig. 4.2, J). The above findings therefore indicated
that proinflammatory responses via IL-1β , MCP1 and TNF-α are induced by early MC
exposure in DIO mice. To study the effect of early microcystin exposure in NAFLD in
stellate cell proliferation, immunohistochemistry, and mRNA expression of stellate cell
activation marker α-SMA were studied. TGF-β also is studied similarly as α-SMA because
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it has been shown in different researches to be key for fibrogenesis in liver injury outcomes
[57, 127]. α-SMA as well as TGF-β immunoreactivity and their mRNA expression levels
were significantly increased in the early exposure to microcystin followed by HFD
(DIO+MC) mice groups when compared with DIO mice, the lean + MC mice group or lean
(P < 0.001) (Fig. 3.2, D,E,H,I ,K and L).
Early exposure to microcystin followed by HFD will induce hepatic oxidative stress
Oxidative stress is one of the most important pathogenic mechanisms associated
with Liver injury [128, 129] . Evidence based research confirms that 3-Nitrotyrosine
formation in vivo as well as in vitro occurs under various pathological conditions
particularly in liver. 3-Nitrotyrosine (3-NT) is known to be a marker of peroxynitritemediated oxidative damage in the diseased liver [130, 131]. Results showed that the
immunoreactivity of 3-nitrotyrosine as analyzed by immunohistochemistry in early
exposure to microcystin followed by HFD (DIO+MC) mice groups was significantly
increased compared to DIO mice, the lean + MC mice group or lean (Figure 4.3A and
B)(P<0.05). This indicates that early exposure to microcystin has a clear role in the
development of tyrosine radicals and tyrosine residue nitration in the high fat diet with
early microcystin exposure group.
Liver injury after early microcysin exposure is associated with inflammasome
activation
There are many studies indicating the role of NLRP3 inflammasome activation in
different liver injuries as a major contributor to hepatocyte damage, activation of immune
cells and hepatic inflammation [132-135] . Our group also has shown that microcystin can
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mediate peroxynitrite species via NOX2 in inflammasome activation at intestinal
inflammatory pathology [122]. To investigate whether early exposure to microcystin can
result in inflammasome activation in the liver tissue, we measured mRNA expressions of
the NLRP3 as well as ASC2 inflammasome sub-units. We also conducted colocalization
events of both subunits for ASC2 and NLRP3 to demonstrate efficient assembly of the
inflammasome complex. Results showed that there was an increase in mRNA expression
levels for NLRP3 as well as ASC2 inflammasome subunits in the early exposed to
microcystin with HFD mice (DIO+MC) compared to with DIO control mice alone, lean
mice exposed to MC, or lean mice (Figure 4.4,A,B,C, and D) (P<0.05). However, Caspase1
mediated IL-1β as well as IL-18 release is completely associated with

NLRP3

inflammasome activation in Kupffer cells [92, 136]. To investigate whether early exposure
to microcystin can result in release IL-1β and IL-18 as a pro-inflammatory cytokines
depends on inflammasome activation, we measured mRNA expression that were assessed
by qRT-PCR and their immunoreactivity, which were assessed by immunofluorescence
microscopy. Results showed that there was an increase in mRNA expression levels for IL1β and IL-18 genes in mice that have early exposure to microcysin followed with HFD
(DIO+MC) as compared to with DIO control mice alone, lean mice exposed to MC, or lean
mice (Figure 4.5, D and E) (P<0.05). Results also showed increased immunoreactivity of
IL-1β and IL-18 in early exposed to MC with HFD (DIO + MC) mice groups as compared
with DIO control mice alone, lean mice exposed to MC, or lean mice (Figure 4.5, A,B and
C) (P<0.05). Furthermore, to investigate the role NLRP3 inflammasome activation and
subsequent liver injury outcomes going forward, we used NLRP3 gene-deleted mice
(NLRP3 KO) early exposed to microcystin and fed them with a HFD. The
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immunohistochemistry of 3NT, a marker of peroxynitrite-induced oxidative stress, as well
as Kupffer cell activation marker CD68 were performed. Results showed that there was an
significant increased immunoreactivity of 3NT in early exposed to MC with HFD (DIO +
MC) mice when compared with DIO mice alone, whereas there was a significant reduction
in NLRP3 KO mice groups that early exposed to MC (P = 0.013) (Fig.4.6, A and G).
Results also showed increased immunoreactivity of CD68 in early exposed to MC with
HFD (DIO + MC) mice groups as compared with DIO alone, whereas there was a
significant decrease in NLRP3 KO mice groups that early exposed to MC (P < 0.001)
(Fig.4.6, B and H). The mRNA expression of proinflammatory cytokines CD68, MCP1,
and TNF-α showed a significant increase in early exposed to MC with HFD (DIO + MC)
mice groups, whereas a decrease in NLRP3 KO mice groups that early exposed to MC was
observed (P < 0.001) (Fig. 4.6, M). Moreover, the immunoreactivity of a cytokine known
for its role in fibrosis (TGFβ) using immunohistochemistry staining as well as the
immunoreactivity of stellate cell activation marker (α-SMA) using immunofluorescence
staining were performed. Results showed that there was an significant increased
immunoreactivity of TGF-β as well as α-SMA in early exposed to MC with HFD (DIO +
MC) mice when compared with DIO mice alone, whereas there was a significant reduction
in NLRP3 KO mice groups that early exposed to MC (P < 0.001) (Fig.4.6, C,D,I and J).
Similarly, the mRNA expression of TGF-β and α-SMA genes showed a significant increase
in early exposed to MC with HFD (DIO + MC) mice groups, whereas a decrease in NLRP3
KO mice groups that early exposed to MC was observed (P < 0.001) (Fig.4.6, N). Caspase1
mediated IL-1β as well as IL-18 release also is evaluated. Results also showed increased
immunoreactivity of IL-1β and IL-18 in early exposed to MC with HFD (DIO + MC) mice
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groups as compared with DIO mice alone, whereas there was a significant reduction in
NLRP3 KO mice groups that early exposed to MC (P < 0.001) (Fig.4.6, E,F,K and L). The
mRNA expression of IL-1β and IL-18 genes showed a significant increase in early exposed
to MC with HFD (DIO + MC) mice groups, whereas a decrease in NLRP3 KO mice groups
that early exposed to MC was observed (P < 0.001) (Fig.4.6, O). Together this data
suggested that early microcystin exposure activated Kupffer as well as stellate cells,
increased inflammation, and were NLRP3 inflammasome assembly dependent.
4.4 DISCUSSION
The present study reports the role of early microcystin exposure in exacerbating
livery injury outcomes. Moreover, this study suggests the role of assembling the NLRP3
inflammasome complex in the progressing of liver injury. The findings reported in this
study indicate that early MC-LR exposure induced increased inflammation, increased
stellate cell activation, and early fibrosis starting. In addition, results showed that mice
primed with subchronic doses of microcystin for two weeks immediately after their
weaning followed by a high fat diet has increased serum ALT levels in comparison to the
other groups. These are collectively considered classical signs for early NAFLD link
inflammation. Using these mice models that are highly translatable to humans

in

generating the above data is suggesting that children and infants may be at risk of exposure
to microcystin and subsequent hepatic injury, particularly if they are obese. These findings
are connected to pediatric epidemiology data, as the NAFLD prevalence is increasing
among children that are overweight in comparison to children who are not. This can have
huge implications for them, causing NAFLD cases to advance to NASH. Our findings also
assume relevance in clinical settings research using reports from Center for Disease
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Control and Prevention, as it has been published that there are positive associations
between obesity and progressions of chronic liver pathologies such as NASH.
It has been shown by using the pharmacological inhibitor for NLRP3 activation in
a mouse model of NASH, that liver injury including liver inflammation and fibrosis
processes have been reduced [137]. The same findings have been shown by using knockout
mouse models. There are also many triggers such as lipotoxic lipids, like free fatty acid,
and diacylglycerols for hepatic NLRP3 inflammasome activation in NASH [138].
Moreover, the conceptual “two hit” or “multi hit” paradigm can be applied here by using
environmental contaminants such as early microcystin exposure in DIO mice models for
activation of NLRP3 inflammasome. In our study, in order to understand the role of early
exposure to the microcystin in liver injury at diet induced obesity mice , we studied the
activation of NLRP3 inflammasome using proteins as well as mRNA expression for genes.
NLRP3 inflammasome, if activated, will result in activation of pro-caspase1 and pro-IL1β. That in turn will be converted to IL-1β, which is known to have a key role in NASH
development within NAFLD spectrum [133]. Our findings of increased NLRP3 and ASC2
assembly using dual staining for colocalization proved the process of inflammasome
activation following priming with microcystin in DIO models. Subsequent to
inflammasome activation there are increases in markers of Kupffer cells activation (CD68)
as well as stellate cell activation (α-SMA) while at the same time there were observed
decreases of all the above markers in NLRP3 KO mice. IL1B as well as IL18 are also
shown to be increased in their expression in mice primed with microcystin in DIO models
, while their level of expressions is attenuated in NLRP3 KO mice.

81

It has been shown by our group that oxidative stress mediated by peroxynitrite
generation plays a central role in activating Kupffer cells during early steatohepatitic
process in NASH [6]. We and others also have shown earlier that peroxynitrite generation
in NAFLD creates a stable nitrated residue of tyrosine called 3-nitrotyrosine (3NT) protein
[6, 54]. This protein is established as a biomarker for oxidative stress in liver injuries [130,
139]. Moreover, we published data that provided mechanistic cues in microcystin exposure
that induced NASH pathology, wherein Kupffer cells could be the key cell site for the
generation of NOX2-dependent ROS. In our study here, we found an increase at level of
3-NT in mice primed with microcystin in DIO models while also finding a decrease of this
ROS marker in NLRP3 KO mice. This can give us a good evidence for the role of NLRP3
activation in ROS generation .
Our results showed significant increase in expression levels of α-SMA and TGF-β
in mice primed with microcystin in DIO models , while their level of expressions is reduced
in NLRP3 KO mice. The fibrosis also was analyzed by showing significant increased
morphometry of picro sirius red in liver tissues slides of mice primed with microcystin
in DIO models. This indicates that early exposure to microcystin can cause early fibrosis ,
which is considered a characteristic for early NAFLD-linked inflammation.
In summary, our results clearly assumed that early exposure to microcystin causes
liver injury outcomes in high fat diet-induced obesity and is dependent on NLRP3
inflammasome activation. Drinking water or swimming in water sheds that have
microcystin levels higher than EPA permissible limits particularly in childhood stage,
might result in adult hepatic injury. Moreover, it can result in the development of metabolic
syndrome including NASH if the individual has tendencies for obesity.
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Figure 4.1. Early priming with microcystin for two weeks in juvenile mice liver induces
liver injury . A: representative histological images of liver sections stained with
hematoxylin-eosin (H&E), from lean mouse control and early primed with microcystin
,MC (n = 3). B: representative histological images of the same groups of mice stained with
picrosirius red (PicroS). C: Representative immunohistochemistry images of liver sections
of the same groups of mice immunostained with CD68. Images were taken at ×20
magnification. D: Representative immunofluorescence images of liver sections of the
same groups of mice immunostained with α-SMA (grean) counterstained with DAPI
(blue). Images were taken at ×40 magnification. Morphometric analysis of PicroS(E)
83

CD68 (F), and α-SMA (G) in lean mouse control and early primed with microcystin ,MC
groups (n = 3/group). Morphometric analysis was expressed in percentage of positive
immunoreactive area per regions of interest (ROIs) (3 ROIs/liver section). H: Quantitative
RT-PCR analysis of mRNA expression of CD68, TNF-α , MCP1, IL-1β, and α-SMA in
lean, lean + MC livers. The mRNA expressions were normalized with 18s and presented
as fold change of lean group. *P < 0.05. Results were expressed as means ± SE.
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Figure 4.2. Early exposure to microcystin followed by HFD will exacerbate liver injury .
A: representative histological images of liver sections stained with hematoxylin-eosin
(H&E), from lean mouse control, early exposed to microcystin (MC),DIO and DIO+MC
(n = 3). B: representative histological images of the same groups of mice stained with
picrosirius red (PicroS). Representative immunohistochemistry images of liver sections of
the same groups of mice immunostained with CD68 (C), and TGF-β (D). Images were
taken at ×20 magnification. E: Representative immunofluorescence images of liver
sections of the same groups of mice immunostained with α-SMA (grean) counterstained
with DAPI (blue). Images were taken at ×40 magnification. Morphometric analysis of
PicroS (F) CD68 (G),TGFβ (H) and α-SMA (G) in lean mouse control and exposed to
microcystin (MC),DIO,DIO+MC groups (n = 3/group). Morphometric analysis was
expressed in percentage of positive immunoreactive area per regions of interest (ROIs) (3
ROIs/liver section). Quantitative RT-PCR analysis of mRNA expression of (J)
CD68, TNF-α , MCP1, IL-1β, (K) TGF-β , and α-SMA (L) in lean, lean + MC, DIO, and
DIO+MC livers. The mRNA expressions were normalized with 18s and presented as fold
change of lean group. M: quantification of serum alanine aminotransferase (ALT) level
and comparison between lean mouse control and exposed to microcystin
(MC),DIO,DIO+MC groups (n = 3/group). *P < 0.05. Results were expressed as
means ± SE.
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Figure 4.3. Early exposure to microcystin followed by HFD will induce hepatic oxidative
stress. A: representative immunohistochemistry images of liver sections immunostained
with 3-NT, from lean mouse control, early exposed to microcystin (MC),DIO and
DIO+MC (n = 3). Images were taken at ×20 magnification. B: Morphometric analysis of
3-NT in lean mouse control and exposed to microcystin (MC),DIO,DIO+MC groups (n =
3/group). Morphometric analysis was expressed in percentage of positive immunoreactive
area per regions of interest (ROIs) (3 ROIs/liver section). *P < 0.05. Results were
expressed as means ± SE.
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Figure 4.4. Early exposure to microcystin followed by HFD induces NLRP3
inflammasome activation. A: representative images of NLRP3 (red) and ASC2 (green)
immunofluorescence counterstained with DAPI (blue) in in lean mouse control and
exposed to microcystin (MC),DIO,DIO+MC groups (n = 3/group). Images were taken at
×40 magnification. B: morphometric analysis of NLRP3 and ASC2 colocalization
expressed in percentage of positive colocalized immunoreactive area per region of interest
(ROI) (3 ROIs/liver section, n = 3 each group). Quantitative RT-PCR analysis of mRNA
expression of NLRP3 (C) and ASC2 (D) in lean, lean + MC, DIO, and DIO+MC livers.
The mRNA expressions were normalized with 18s and presented as fold change of lean
group. *P < 0.05. Results were expressed as means ± SE.
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Figure 4.5. Early exposure to microcystin followed by HFD releases IL-1β and IL-18.
representative images of IL-1β (red) (A), and IL-18 (red) (B) immunofluorescence
counterstained with DAPI (blue) in in lean mouse control and exposed to microcystin
(MC),DIO,DIO+MC groups (n = 3/group). Images were taken at ×40 magnification.
Morphometric analysis of IL-1β (C) and IL-18 (D) in lean mouse control and exposed to
microcystin (MC),DIO,DIO+MC groups (n = 3/group). Morphometric analysis was
expressed in percentage of positive immunoreactive area per regions of interest (ROIs) (3
ROIs/liver section). E: Quantitative RT-PCR analysis of mRNA expression of IL-1β and
IL-18 in lean, lean + MC, DIO, and DIO+MC livers. The mRNA expressions were
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normalized with 18s and presented as fold change of lean group. *P < 0.05. Results were
expressed as means ± SE.
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Figure 4.6. The activation of Kupffer cells, hepatic stellate cells, and an inflammatory surge
in early microcystin (MC) exposure are mediated by NLRP3 inflammasome activation.
Immunohistochemistry images of liver sections immunostained with 3-NT (A), CD68 (B),
and TGF-β (C) from DIO, DIO+MC , and NLRP3 KO mice treated with MC (n = 3).
Images were taken at 20X magnification. representative images of α-SMA (Green) (D)
,IL-1β (red) (E), and IL-18 (red) (F) immunofluorescence counterstained with DAPI (blue)
in DIO, DIO+MC , and NLRP3 KO mice treated with MC (n = 3/group). Images were
taken at ×40 magnification. Morphometric analysis of 3-NT (G), CD68 (H), and TGF-β
(I) IL-1β (J) and IL-18 (K) in DIO, DIO+MC , and NLRP3 KO mice treated with MC
(n = 3/group). Morphometric analysis was expressed in percentage of positive
immunoreactive area per regions of interest (ROIs) (3 ROIs/liver section). Quantitative
RT-PCR analysis of mRNA expression of CD68, MCP1,TNF-α (L),TGF-β,α-SMA
(M), IL-1β and IL-18 (N) in DIO, DIO+MC , and NLRP3 KO mice treated with MC livers.
The mRNA expressions were normalized with 18s and presented as fold change of DIO
group. *P < 0.05. Results were expressed as means ± SE.
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CHAPTER 5
CONCLUSION
Obesity is a condition which arises due to the influence of multiple factors.
According to Brehm and D’Alessio, some of these factors are external in the environmental
predisposition while the others arise internally from the genetic structure [140]. There is a
higher level of significance associated with the influence of genetic factors in the nature
and development of an individual. However, recent trends also indicate that other factors
in an individual such as their social behavior, including education levels, food, and dietary
patterns, as well as the level of physical activity, all influence the prevalence of obesity.
Each of these factors influences the prevalence and development of obesity because they
predispose an individual to conditions that influence and support there development and
progress. Obesity as a genetic underlay also depends on these factors to manifest and
actively develop because, in their absence, it is impossible to develop such a set of
background attributes.
Education levels influence an individual’s understanding of aspects such as diet and
nutrition. Reduced levels of education mean that households lack the proper form of access
to information and knowledge that would allow them to develop and sustain a healthy
lifestyle [141]. The food market also defines the types of nutritional components which
households access. The rise in the fast food market supports and leads to a higher level of
obesity due to its level of sugars and fats. The market also makes it harder to access healthy
alternatives. Further, eating patterns are a major factor in the prevalence of obesity [140].
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Practices such as binge eating, late eating, and attributes of frequency all have an influence
on the presence and influence of obesity in an individual or a family setting. Ultimately,
physical activity defines the level of exercise in an individual and influences how they use
their food uptake.
Jiang et al. (2016) indicate that obesity has a direct correlation with the presence
and level of hypertension in an individual [142]. Essentially, obesity arises when an
individual is unable to use up their extra food intake through energy expenditure.
Therefore, the energy accumulates as fat and glycogen reserves in various parts of the body.
An increase in weight due to the deposits and the specific areas where these deposits arise
influence the circulatory system. Obesity arises due to associated conditions such as
arteriosclerosis where fat and mineral components accumulate in blood vessels. An extra
amount of weight also puts additional pressure on the blood vessels to supply blood deeper
into the tissues. There is a larger amount of energy expenditure that is necessary to support
that higher level of activity in the tissues, which is the reason there is need for more flow
of blood into the tissues.
Further, there is a correlation between obesity and inflammatory, metabolic
disorders. Some of these conditions arise due to genetic conditions or other factors
surrounding an individual. A common example of these conditions is a non-alcoholic fatty
liver disease which arises due to the abnormal deposition of fats in the liver [143]. The
liver performs a role in detoxification and component breakdown through the process of
oxidation. However, when there is an extra amount of deposition in the liver, there is a
resultant effect of oxidative stress which leads to inflammation, injury, and dysfunction
within the hepatic cells in the liver. The progression of non-alcoholic fatty liver disease
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creates an adverse effect because most of its progress is asymptomatic. Therefore, the
condition can arise and progress to a point where there is extensive hardening and scarring
of tissues before it is possible to detect. Therefore, its effects are devastating to the affected
subject.
Previous studies have shown that pollutants from the environment behave in the
liver as a "second/multiple hit" in order to augment NAFLD pathophysiology [6, 8]. For
example, our group has shown that chronic low doses exposure to Bromo-dichloromethane
(BDCM), which is known to be a prevalent by-product of water disinfection, can induce
liver injury in preexisting NAFLD condition causing non-alcoholic steatohepatitis (NASH)
via oxidative stress mediated by CYP2E1 in obese mice [6]. This idea has been translated
into epidemiological study where using the U.S. Data from NHANES 1999–2006 as crosssectional study has revealed higher concentrations of the alanine aminotransferase (ALT),
which is an enzyme that is used as a common marker of liver injury in people exposed to
greater concentrations than average concentrations of trihalomethane brominated in their
blood with prevalence odds ratios (ORs) equal to 1.35 times for its level (95% CI: 1.02,
1.79) [144]. In both the United States and other countries, total trihalomethanes
concentrations exceeding the benchmark exposure threshold as well as obesity prevalence
continue to be reported [144].
In the present study, I examined the different basic molecular mechanisms of
hepatic injury in NASH that is induced by microcystin exposure. Inhibition of PP2A both
via endogenous and exogenous routes can be a cause of livery injuries including in adult
as well as juvenile age groups. An important public health issue is an increase in obesity
prevalence as well as an increased prevalence of NAFLD among them. In NAFLD
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progression to advanced NASH stage, the concept of two-hit and the multi-hit theory plays
an

important

role,

in

which

an

environmental

agent

apart

from

obesity

is a significant cause of liver injury. We found in our study that microcystin is activated
Kupffer cells as well as hepatic stellate cells, that release the proinflammatory mediators
involved in progression of NAFLD to NASH.

Different studies have shown that

environmental toxicants exposure, which act as second hits, can regulate NOX2 activation
in NAFLD condition. In our study we found in Kupffer cells that microcystin exposure will
increase the activation of NOX2 and tyrosine nitration. This has been shown in vitro by
visualizing the significant increase in GP91 phox-p47 phox colocalization events in
Kupffer cells that have been exposed to leptin with MC as compared with other cell groups.
In vivo also, we have been shown the significant increase in the colocalization events
of GP91 phox-p47 phox in NAFLD mice that have been exposed to microcystin as
compared to other groups. Moreover, several publications have shown that microRNA 21
(miR21) in NAFLD and NAFLD-associated kidney inflammation is upregulated there. If
upregulated, miR21 also has been shown to regulate the NAFLD fibrogenesis via SMAD
pathway. In our study, we have shown that microcystin can activate the miR21 in
progressive NASH. We found in NAFLD mice that were exposed to microcystin that there
is a significant increase in miR21 level of expression among them as compared to other
groups. Interestingly, P47 phox KO mice that were exposed to microcystin showed a
significant decline in miR21 expression level as compared to NAFLD mice that were
exposed to microcystin. In addition, we found that miR21 KO as well as P47 phox KO
mice that were exposed to microcystin showed a significant decrease in immunoreactivity
of CD68, CD11b, and α-SMA. These are known biomarkers for Kupffer cells as well as
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hepatic stellate cells. This indicates that microcystin exposure can activate the NOX2induced miR21 which plays an important role in the activation of Kupffer cells and stellate
cells. Mechanistically, immortalized Kupffer cells as well as stellate cells treated with
pharmacological inhibitors such as apocynin ,nitrone spin trap DMPO, or phenyl boronic
acid (FBA) with microcystin and leptin exposure showed a decrease in miR21 levels ,
activation of both Kupffer and stellate cell , and a decrease in inflammatory cytokines
release. Moreover, using the same pharmacological inhibition in cells primed with leptin
and co-exposed to microcystin showed attenuation in Gli 1, PTCG1, IHH , SHH gene
expression, hallmarks for hedgehog signaling activation in NAFLD.
We have also proved in our research that M1 phenotype increases in Kupffer cells
via the same pathway by showing adaptation to an elongated morphology, activation of
iNOS and release of nitric oxide. Further we showed that blocking of the AKT pathway
using AKT inhibtor decreased the ability of PP2A-inhibitor such as microcystin in
induction of NOX2 activation and miR21 upregulation.
In the juvenile mice study, we primed them with microcystin-LR (MC-LR) for two
weeks after the end of weaning followed by high fat diet for four weeks . This study aimed
to be translatable to what has been seen in clinical data. This is because it has been reported
by American Academy of Pediatrics that there is a risk of early exposure to microcystin in
infants as well as children. In our study, we have shown that early exposure to microcystin
can increase proinflammatory cytokines and chemokines in diet induced obesity model as
compared to other groups. Early exposure to microcystin can also increases the serum
alanine aminotransferase (ALT) as compared to the other groups. Interestingly, we have
shown the significant increase in the colocalization events of NLRP3-ASC2 in DIO mice
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model that was primed with microcystin as compared to other groups. Moreover, in
NLRP3 KO mice that were exposed to microcystin showed a significant decrease in the
proinflammatory cytokines and chemokines levels as compared to DIO mice that were
primed with microcystin. In summary, we can conclude that early exposure to microcystin
followed by HFD can exacerbate liver injury outcomes via NLRP3 pathway.
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